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Cattle constitute one of the major livestock species and are an important economi-
cal factor in many countries. The world cattle population is estimated at 1.5 billion
animals, more than 1 billion of them in tropical and subtropical countries. They
are heavily exposed to numerous bacterial infections, which drastically affect their
well-being as well as their productivity. Infectious diseases also play an important
economical role in cattle.
This book discusses important bacterial diseases and suggestive prevention strate-
gies based on progress in this field. It includes four sections and five chapters that
provide the most common diseases and an overview of the essential methods for
their prevention and control.
The book will be useful to researchers and students of veterinary sciences as well as
those who are interested in cattle production.
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Many diseases in modern animal farming are thought to have a direct link to the 
environment with the change of intensive systems with high animal densities on 
specialized farms; a change in the character of animal diseases took place [1].
Diseases no longer follow the traditional pattern, whereby one specific pathogen 
provoked clear clinical symptoms with a specific pathology. Intensification also 
meant that the animal became increasingly dependent on mechanical equipment for 
mechanical ventilation, feeding, and manure removal.
The considerable increase in herd size and the close contact between animals 
favor a quick passage of pathogens, which can lead to an increase in virulence and 
an increased infection pressure [2]. Some animal breeds are productive but may 
lack sufficient disease resistance and are sensitive to relatively small perturbation in 
their artificial environment, such as in temperature or air supply.
In contrast to the classical disease of specific etiology, these new disorders are 
called multifactorial diseases. Multifactorial diseases changed the pattern of diseases, 
morbidity, and productivity considerably. The characteristic of a multifactorial disease 
is that there is a variety of internal and external factors involved, and none of the fac-
tors alone can produce the disease itself. There are various formulations of the laws of 
causation, which are applicable to multifactorial infectious and noninfectious diseases 
[3]. The unified concept of causation by Evans marshals “formal epidemiology”  
can be applied where a causal hypothesis can be sufficiently probable to provide the 
rational basis for prophylactic and therapeutic measures. The causation of modem 
infectious diseases by the relationships between pathogen, host, route of transmis-
sion, and environment makes the transition of an infection into a disease possible. 
The external factors representing the environment include the physical, chemical, 
and biological environment, housing, management, feed, and water. Together with 
pathogens or facultative pathogens, these factors influence well-being, health, and 
performance. A disease, however, will develop only if the “internal factors” of the 
animal are unable to respond properly. The most important internal factors are 
genetic disposition (e.g., lack of resistance or adaptation, hormonal dysfunction) and 
immunity (e.g., maternal antibodies, immunosuppressant).
The aim of this chapter is to inform owners, veterinary professional, and others 
who are interested in Advanced Veterinary Science dealing with those bacterial 
infectious diseases, which occur relatively frequently in dairy and beef cattle and 
focus on general principles for the prevention and control of these diseases, provid-
ing detailed information on each disease. The information includes the following: 
economic impact, recognition of the disease, method of prevention for the spread 
3
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of bacterial diseases between animals in the farm, how to make the animals resist 
the disease, and the treatment of infected animals.
2. Materials and methods
A microbial agent is a microorganism that is capable to cause disease in animal. 
Pathogenicity is the capability to induce disease in an animal. Pathogenic bacteria 
express their pathological effect by means of their infectious aggressiveness (virulence), 
a term which refers to the level of pathogenicity of the microbial organism. Hence, the 
factors of virulence of a pathogen are any of its genome, biochemical characters, and 
structure that give the ability to induce disease in an animal. Domestic livestock have 
always suffered from a wide range of bacterial diseases. As livestock are concentrated 
in larger numbers, the problems of major epidemic have become more severe.
2.1 Cycle and routes of infection
The epidemiologic triangle (triad model) explains that infectious diseases are 
produced from the interaction of a causative agent, susceptible animal (host), and 
environmental surrounding. More attentionally, transmission of the causative agent 
results when the agent leaves its animal (host or reservoir) through a way of escape 
(portal of exit), is produced by some means of transmission, and enters through a 
specific entrance (portal of entry) to infect a susceptible animal. This cycle is some-
times called the chain of infection.
When speaking of infectious diseases, exposure assumes a tailored meaning, 
namely, encountering the infectious agent in a fashion that allows for agent trans-
mission. Therefore, knowledge of transmission mechanisms is vital for understand-
ing the epidemiology of infectious diseases.
This chapter is focused on major bacterial diseases that can cause significant loss 
or concern for dairy cattle, beef rearing, and fattening enterprises, as well as practi-
cal steps that can be taken to prevent the occurrence of such diseases and regulatory 
control measures that should be taken on a specific disease.
3. Results and discussion
3.1 Bovine tuberculosis
Bovine tuberculosis is a chronic bacterial disease of cattle that sometimes affects 
other mammalian species. This disease is a major animal disease that can be trans-
mitted to humans, usually by inhaling aerosol or ingestion of unpasteurized milk. 
The model strategy for the control of diseases in domestic animals includes regular 
field trials, quarantine, and sanitary wards for infected herds [4]. This prevents the 
spread of the disease outside the population, while slaughtering infected animals 
reduces infection from within the farm.
A system of control for the tuberculosis disease in cattle (TB) is by the exami-
nation of cattle, which includes slaughtering positive animals (system of test and 
slaughter) along with the isolation of herds and inducing herd immunization 
against the disease by vaccination [5]. The health state of the herd is represented by 
integrating mathematical formulations that express the period of herd quarantine 
(isolation). The system of TB control in New Zealand can be applied and used as an 
example (vaccination as control strategy). The induction of such system suggests 
that vaccine efficacy is more than 95%, reaching 95% of target TB levels within  
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6 years. These results suggest that the complementary strategy for immunization 
and vector control may be more promising than vaccination alone [5, 6].
3.2 Campylobacter enteritis (Vibrionic enteritis, vibriosis)
Intestinal campylobacteriosis occurs by Campylobacter jejuni or Campylobacter 
coli. Although they compete in the digestive system of many species, they can cause 
diarrhea, especially in small animals. Campylobacter fetus can also cause reproduc-
tive diseases and abortion in cattle. Campylobacter spp., especially C. jejuni and 
C. coli, are a major cause of enteritis in humans. Additional species cause venereal 
diseases in sheep and cattle. Many animals carry Campylobacter spp. without any 
symptoms, throwing the organism in their feces or stools. Bulls can be vaccinated 
annually against the campylobacteriosis [5].
Vaccinations are also available for cows and make the animal very resistant 
to infection. It can help biosecurity and the examination of bulls purchased in 
the identification of the disease. If the ox has to be bought, the best policy is the 
younger the better. If you are forced to buy a mature bull, use antibiotics before 
using it to breed cows and use them on a small number of cows only so that their 
fertility can be recorded before they are used for service in the original herd.
3.3 Anthrax
Anthrax is caused by Bacillus anthracis, a spore and a gram-positive rod in the 
Bacillaceae family. The anthrax is completely malignant with plasmid pX01, which 
denotes the trioxide complex of the protein, and pX02, which encodes the capsule genes. 
B. anthracis is very homogenous genetically. However, researchers identified several 
genetically distinct groups that appear to be derived from cloned animals. Some of these 
clones are distributed worldwide, while others are in limited geographical areas [1, 5].
Infection is usually acquired through the ingestion of contaminated soil, feed, or 
mixed fodder. Anthrax spores in soil are very resistant and can cause disease when 
ingested even after years of outbreaks, the spores are brought to the surface due 
to wet weather or by deep tillage. When the disease appears or is inhaled by rumi-
nants, the disease appears. In the event of an outbreak, the bodies of succumbed 
animals should be buried or burned properly and the carcass or body forbidden be 
open (because exposure to air results in forming spores). The buildings, region, or 
houses should be put under quarantine until all susceptible animals are vaccinated.
A prophylactic measure by vaccination in endemic areas is utmost significant. In 
spite of vaccination seeming to prevent outbreaks, veterinary authorities may forget 
to vaccinate susceptible animals when the disease does not occur for several years 
(spores of the anthrax stay alive for long intervals), so the risk is always present. 
Anthrax disease is recorded in the list of the World Health Organization (WHO), 
Animal Health Code (OIE), 2011, (Article 1.2.3) and must be reported to the OIE 
(Chapter 1.1.2—Disease Notification and Epidemiological Information).
4. Bacterial respiratory affections
4.1 Hemorrhagic septicemia
The disease results from certain serotypes of Pasteurella multocida, a gram-
negative coccobacillus, which is often used as a nasopharyngeal animal. The Asian 
cultivar B:2 and the African serotype E:2 (Carter and Heddleston classification), 
corresponding to the classification of 6:B and 6:E (Namioka-Carter), are the two 
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main culprits. A:1 and A:3 have been associated with a condition similar to HS in 
cattle and buffaloes in India with pneumonia in the first place leading to death. 
The letter refers to the antigen of the wallet and indicates the number of physical 
antigens [1, 3].
4.2 Contagious bovine pleuropneumonia
Caused by Mycoplasma mycoides subsp. Mycoides (the bovine biotype). 
Mycoplasma mycoides are a small colony type, belonging to the Mycoplasmataceae 
family. It can be categorized into two major lineages [1–3]:
1. Isolates from Europe
2. Isolates from Africa
Other strains of M. mycoides were retrieved from other animal species (goats 
or sheep). The other strains are similar antigenically to bovine strains; they do not 
appear to be pathogenic to cattle, but they may cause diseases other than CBPP in 
small ruminants.
4.3 Mannheimia haemolytica
Serotype 1 of Mannheimia haemolytica is the common isolated bacteria of the 
cow’s respiratory tract with BRD. Pasteurella multocida is also an important reason 
of pneumonia. Histophilus somni is constantly recognized as an important pathogen 
in bacterial respiratory disease (BRD). These bacteria are normal inhabitants of the 
nasal pharynx of cattle. When pulmonary abscess occurs, it is generally associated 
with chronic pneumonia.
4.4 Trueperella pyogenes
Trueperella pyogenes is frequently isolated in bacterial respiratory disease (BRD).
4.5 Chronic suppurative pulmonary disease
Chronic lung suppurative disease develops due to unsuccessful treatment 
or incomplete recovery from previous lung attacks. The outbreak of bacterial 
infection in the lungs is often associated with a stressful event such as trans-
port, sale, or the most common. Salmonellosis, especially Salmonella infection 
(Salmonella Dublin infection), and Johne’s disease are other examples of postna-
tal reinfection.
4.6 Mycoplasma pneumoniae
Mycoplasma bovis is one of the emerging causes of respiratory diseases and 
arthritis in cows and in dairy calves and fattening calves. Experimental infection 
usually leads to a lack of access to mild signs of respiratory disease, but malignant 
strains that cause severe lung disease have been identified in calves [5].
1. The greatest risk is the purchase of cattle or calves, clinically or subclinically 
infected with Mycoplasma bovis.
2. Maintaining a completely closed herd policy is the best way to reduce the risk of 
introducing Mycoplasma bovis.
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3. If you have to buy cows or heifers, there is always the risk of buying the infec-
tion. This risk can be minimized through a detailed history, only the purchase 
of herds of few somatic cells, and by examining the herd from which the 
animals were purchased, or individuals who were quarantined before entering 
the main herd, by means of serum tests.
4. Feeding milk waste is not recommended to calves where Mycoplasma bovis has 
been diagnosed.
5. Although there are no commercial vaccines licensed in Europe for Mycoplasma 
bovis, APHA and other companies are licensed to produce a self-produced 
vaccine.
5. Control of bacterial respiratory affections
The pathological mechanism includes environmental and management pres-
sures and perhaps an initial viral infection followed by secondary bacterial infection 
in the lower respiratory tract. Stress results from environmental and husbandry fac-
tors, including inadequate ventilation, mixing with the addition of calves to a spe-
cific group, overcrowding, and feeding practices such as poor quality milk replacer. 
Failure of the negative transmission of mother immunity (maternal antibodies) is a 
critical factor for the appearance and induction of the disease [7].
Mycoplasma mycoides, Pasteurella multocida, Mannheimia haemolytica, and 
Mycoplasma bovis are the most causes of bacterial respiratory affections. The risk and 
degree of pneumonia can be ameliorated by good managemental practices, adequate 
housing, and adequate ventilation, good breeding, and good nursing care. Control 
starts by immunization of mothers (vaccinating cows) against certain respiratory 
pathogens at 3–4 weeks before calving to produce good quality of the antibodies in 
colostrums. Newly born calves should receive good quality of colostrums of 8–10% 
body weights in the first 6 hours after parturition. Newborn calves should be indi-
vidually placed in adequate houses and consumed whole milk or high-quality milk 
substitutes with a fiber content less than 0.25% for a period of 8–12 weeks of age.
Prophylactic measures should be taken such as:
• Long-acting antibiotics  should be given upon arrival  of animals after trans-
portation of cattle in the farms.
• Prophylaxis has been shown to significantly:
a. reduce morbidity;
b. improve gain; and
c. add medicaments in ration or drinking water that have limited value because 
oral antibiotics are poorly absorbed in ruminants.
5.1 Bovine brucellosis
Bovine brucellosis, caused by Brucella abortus bacteria, is an economically impor-
tant cause of abortion in cows. Abortion also affects other species, including bison, 
buffalo, and elk; some species are host maintenance for this organism. Infection in 
the wild animals can hinder efforts to eradicate the disease in bovine. In the same 
time, B. abortus transmitted to humans (zoonotic disease). In humans, brucellosis 
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3. If you have to buy cows or heifers, there is always the risk of buying the infec-
tion. This risk can be minimized through a detailed history, only the purchase 
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vidually placed in adequate houses and consumed whole milk or high-quality milk 
substitutes with a fiber content less than 0.25% for a period of 8–12 weeks of age.
Prophylactic measures should be taken such as:
• Long-acting antibiotics  should be given upon arrival  of animals after trans-
portation of cattle in the farms.
• Prophylaxis has been shown to significantly:
a. reduce morbidity;
b. improve gain; and
c. add medicaments in ration or drinking water that have limited value because 
oral antibiotics are poorly absorbed in ruminants.
5.1 Bovine brucellosis
Bovine brucellosis, caused by Brucella abortus bacteria, is an economically impor-
tant cause of abortion in cows. Abortion also affects other species, including bison, 
buffalo, and elk; some species are host maintenance for this organism. Infection in 
the wild animals can hinder efforts to eradicate the disease in bovine. In the same 
time, B. abortus transmitted to humans (zoonotic disease). In humans, brucellosis 
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causes debilitating and sometimes chronic disease that affects different organs. 
Many cases are the result from the contact with infected animals but also occur 
from ingestion of contaminated food [5, 8].
In low-prevalence conditions, control of bovine brucellosis (BB) can be achieved 
by combining test and slaughter programs with stringent biosecurity measures and 
removing of reactors. However, in high-incidence cases, immunization can help the 
control of outbreaks that reduce the rate of infection at both individual and herd levels.
Vaccination with RB51 permits a rapid reduction in the susceptible herds and 
flocks in an endemic regions, resulting in a rapid decline in the incidence of disease 
from occurring; this, combined with the frequent testing, permitted the control and 
eradication of the disease after 3–5 years.
A combination of strict biosecurity measures, strong diagnostic pressure, and 
vaccination program is able to reduce the spread of BB. The RB51 vaccination allows 
rapid reduction in vulnerable populations in a highly contagious environment, 
contributing to a rapid decline in individual infection; this, together with repeated 
testing, allowed control and eventual elimination after 3–5 years
5.2 Listeriosis
Listeriosis is an infectious disease caused by bacteria, Listeria monocytogenes. It is 
an animal disease. Listeriosis is primarily the winter sickness of the winter feedlot 
or ruminant dwells. The less acidic pH of the corroded silage enhances the multi-
plication of L. monocytogenes. Listeriosis occurs intermittently in cows, where most 
cases are associated with feeding fermented and poorly preserved feeds. Listeriosis 
is an infectious but not contagious disease caused by Listeria monocytogenes, which 
is more common in domestic animals (mammals and domestic poultry), especially 
ruminants, than humans and is sporadic but can occur like an outbreak in ruminant 
farms. Listeriosis is treated with antibiotics, depending on the shape of the disease; 
treatment may take up to 6 weeks or more [5].
High doses are required because of the difficulty in achieving minimum con-
centrations of antibiotics in the brain. Recovery depends on early and aggressive 
antibiotics. If signs of encephalitis are severe, death usually occurs despite treat-
ment. The risk of listeriosis can be reduced by feeding good quality silage with low 
pH. Avoid the bad or decomposed silage or the high-grade silage (a few inches) that 
have been exposed to air. Any remaining residual fodder should be removed at no 
cost after feeding. Anti-rodents will prevent the spread of bacteria. Vaccines are 
available in some countries, but the results are questionable, leading to questions 
about the cost-benefit of vaccination.
5.3 Leptospirosis
Leptospirosis is a bacterial infection that has identified five common serovars 
causing abortion in cattle: Leptospira canicola, L. icterohaemorrhagiae, L. grip-
potyphosa, L. hardjo, and L. pomona. Leptospirosis is spread by infected urine or 
contaminated water (by mice). Control of Leptospira hardjo in herds depends on a 
range of management decisions to reduce the risk of infection, strategic treatment 
with antibiotics, and vaccination. The main pathway to immunization consists of 
two spaced injections of 4 weeks followed by an annual lift. Vaccination should 
prevent the execration of the microorganism in urine after exposure and protect 
against falling milk and abortion.
In contaminated regions, herds without previous infection of leptospiroses, 
all animals of the herd, including bulls, should be quarantined and isolated for 21 
days and given 25 mg/kg streptomycin two times for 10–14 days interval before 
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entering the herd. Herds of acute leptospiroses infection should be under a com-
prehensive antibiotic treatment to reduce the risk of infection and immunization. 
Herds in an endemic regions should be vaccinated annually. Replacement heifers 
should have completed their vaccination course before first service. As a precau-
tionary measure, streptomycin is added to the semen from bulls held at artificial 
insemination centers.
5.4 Clostridial diseases
These include blackleg disease, malignant edema, black disease, enterotoxemia, 
and redwater disease. All these diseases are common. The organisms form spores 
that can live for long periods in hostile environments and kill cattle quickly, giv-
ing little chance of treatment. Clostridial organisms are mostly normal flora of 
cattle and become only a problem with food stress, injury, management changes, 
parasitism, or other unusual conditions that create a favorable growth environment 
and produce strong toxins. While some diseases rarely occur, most of them occur 
sporadically in herds. Clostridium disease has generally very poor prognosis, and 
the first sign of the disease may be death. Because treatment success is rare, proper 
emphasis is placed on preventive measures [1–3].
Vaccines are widely used in the dairy industry and can be an effective way to 
reduce losses due to these bacteria. Single vaccination with most clostridial vac-
cines does not provide adequate levels of protection and should be followed with 
a booster dose within 3–6 weeks after the first one. Vaccination of calves gives 
protective immunity for 1–2 months, so the adequate immunization for calves is 
obtained through vaccination of the pregnant cows, so that maximum immunity 
and protection are transferred to the calves in the colostrums. Inactivated vaccines, 
including 2–8 of clostridium types, should be taken at the age of susceptibility to 
provide maximum and efficient protection.
Livestock diseases cost farmers millions of pounds a year. In addition to deaths, 
loss of production and loss of animal wealth often(succumbed). Unsolicited 
animals require more food and take longer to grow than health stocks. The good 
animal health program calls for full operation between owner and veterinar-
ians. Farmers must also know that many of the diseases that live in stocks go 
from animal to animal to human. Animals usually acquire diseases either by (1) 
contact with diseased animals or (2) improper sanitation, nutrition, care, and 
management.
Protecting the health of animals by restricting purchases to healthy flocks 
through appropriate quarantine when bringing in new animals through the use of 
sound sanitation, management, and nutrition principles and using appropriate and 
reliable vaccines and vaccines for disease prevention is an economic way to avoid 
disease losses. Prevention of diseases is better and more economical than rushing to 
control disease outbreaks.
There are three kinds of control measures [1]:
1. reducing or eliminating the source or reservoir of infection: (isolation, quarantine, 
and therapy for elimination of bacterial infections via antibiotics and destruc-
tion of an animal reservoir of infection via laboratory tests, environmental 
control, and sanitation);
2. breaking the connection between the source of the infection and susceptible animals 
via disinfection and sanitation; and
3. reducing the number of susceptible animals by mass immunization.
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Immunization can be divided into:
• passive immunization which provides temporary immunity after exposure to a 
pathogen or when a disease threatens to take epidemic pattern; and
• active immunization which protects animals from pathogens and populations. 
During the production of antibodies after effective immunization against the 
disease, there is often an increase in exposure to the disease in question. The 
period in which immunity varies from vaccine to vaccine. For a given disease, 
a second booster dose is required after the first vaccination to achieve stronger 
immunity. Vaccination can be used proactively to give protection but no substi-
tute for good sanitation.
Some vaccines are highly effective:
• Campylobacter fetus vaccine (oil adjuvant vaccine);
• entire Pasteurella whole cell bacterins (free of leucotoxoids to avoid the severity 
of bovine respiratory disease); and
• clostridium toxoids vaccines: Clostridium chauvoei (blackleg) and Clostridium 
septicum (malignant edema ) are highly effective.
Although the vaccine has improved the situation, it certainly did not prevent 
the problem. Other control measures, such as rigorous testing of small bulls and 
the execution or culling of older bulls and late cows, may be more economically 
beneficial. Some vaccines such as leptospirosis are more effective against nonhost 
modified strains of host-adapted strains. The general rule is that if postpartum 
infection leads to a chronic pregnant animal, which means that the animal’s 
immune system has not been able to eliminate the infection, the development of 
a vaccine that stimulates the immune system adequately to prevent infection is 
difficult if not impossible. Therefore, the general view is that vaccines can reduce 
the rate of morbidity (the number of infected animals) and reduce the rate of 
mortality (deaths) of clinical cases. On the other hand, vaccination alone will not 
completely prevent the problem and may be other measures of control is equal or 
more important.
Biosecurity reduces the introduction or the incidence of disease in farms, 
reduces the spread of diseases already found on farms, and reduces the risk of 
disease transmission among farms. Biosecurity controls the transmission of 
pathogens among animals, from animals to fodder, and animals to equipment that 
may relate directly or indirectly to other animals. Biosecurity practices prevent 
the spread of disease by reducing the movement of biological organisms and their 
vectors (viruses, bacteria, rodents, pesticides, etc.) into and within operations 
through animals, vehicles, visitors, employees, pests, and other means. While the 
development and maintenance of biosecurity is difficult, it is the cheapest and most 
effective means of controlling disease, and the disease prevention program will not 
work without it.
Measures for the prevention and control of disease-producing agents:
• Avoid the introduction of causative agents to the farm or the herd (maintain a 
closed herd)
The first step is to avoid purchasing cattle from unknown source or purchase 
from healthy herds.
11
Introductory Chapter: Bacterial Cattle Diseases - Economic Impact and Their Control
DOI: http://dx.doi.org/10.5772/intechopen.83635
Owners would have to strictly adhere to the following requirements:
• use homegrown replacements for maintaining and increasing herd size;
• prevent contacts of stock with other cattle herds;
• use artificial insemination for breeding;
• avoid exhibits or shows; and
• apply restricted measures against visitors.
• Quarantine measures
Isolate new arrivals or the purchased animals and apply the following measures:
• separate housing, feeding, and calving areas;
• prevent contact with other animals;
• prevent manure movement from the isolation area to the rest of the herd;
• quarantine or isolated period is 21–30 days; and
• observe and examine for early disease detection.
• Use laboratory testing before purchasing animals
Owners should take precautions when purchasing animals and use laboratory-
testing programs to prevent the introduction of diseases to their animals, so the 
following precautions should be taken:
• purchase disease-free pregnant or virgin heifers to minimize the risk of 
introducing mastitis;
• vaccinate the purchased animals if necessary according to the vaccinal pro-
gram of the farm;
• purchase animals from healthy and certified herd under the health accredited 
herds program; and
• the purchased animals must be guaranteed or isolated for 21–30 days for:
1. Bacterial culture of milk
2. Blood testing for specific diseases
• Use vaccines
Vaccines are commonly used to protect cattle against respiratory disease and 
abortion. For herd additions, these vaccines may be given during the 21- to 30-day 
isolation period. Vaccination against the diseases should be the cornerstone of every 
herd vaccination program. Consult your veterinarian for specific recommendations 
on these and other aspects of health management for livestock.
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6. Conclusion
Livestock diseases cost farmers millions of pounds a year. In addition to deaths, 
loss of production and loss of animal wealth often. Farmers must also know that 
many of the diseases that live in stocks go from animal to animal to human. Animals 
usually acquire diseases either by (1) contact with diseased animals or (2) improper 
sanitation, nutrition, care, and management.
Protecting the health of animals by restricting purchases to healthy flocks 
through appropriate quarantine when bringing in new animals through the use of 
sound sanitation, management, and nutrition principles and using appropriate and 
reliable vaccines and vaccines for disease prevention is an economic way to avoid 
disease losses. Prevention of diseases is better and more economical than rushing to 
control disease outbreaks.
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Bovine respiratory disease (BRD) is the leading cause of morbidity and 
mortality in feedlot cattle in North America. The BRD is a complex multifactorial 
disease because its onset depends on the interaction between number of factors 
including host, environment, management and viral and bacterial infectious 
agents. The main bacterial pathogens associated with BRD are Mannheimia haemo-
lytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. Treatment and 
prevention of BRD in the feedlots are aimed mainly at bacterial pathogens through 
antimicrobial use. Although antimicrobial use has increased, the prevalence of BRD 
has also increased potentially due to the emergence of multidrug-resistant bacte-
rial pathogens, which poses a serious threat to both animal and public health and 
necessitates the development of alternative antimicrobial approaches to mitigate 
BRD pathogens in feedlot cattle. The objective of this chapter is to provide a brief 
overview of pathogenesis of BRD, to review the current status of antimicrobial 
resistance in bacterial pathogens associated with BRD, and to discuss the potential 
antimicrobial alternative strategies, including probiotic and essential oil (EO) 
approaches, to mitigate bovine respiratory pathogens in feedlot cattle.
Keywords: bovine respiratory disease, bacterial pathogens, antimicrobial resistance, 
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1. Introduction
Cattle production is one of the important industries in North America, account-
ing for $78.2 billion (US) and $10.5 billion (Canada) in cash receipts during 2015. 
A substantial part of this economic benefit is derived from beef sector, where 10.6 
and 2.5 million head of cattle and calves in the USA and Canada, respectively, were 
slaughtered for the beef market in 2015 [1, 2]. The number of beef cattle in the 
North American farms and ranches will continue to increase over the next decade 
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due to the growing red meat demand by an increasing world population, with an 
estimated increase from 7.6 billion people in 2017 to 8.6 billion people in 2030 [3].
Despite advances in veterinary medicine, animal husbandry and animal wel-
fare, economic impacts of cattle disease on the beef cattle industry still remain 
significant, with BRD being the most significant health problem in modern feedlot 
industry in North America. Bovine respiratory disease is commonly associated 
with pneumonia in nursing beef calves and recently weaned feedlot cattle. Cattle 
are mostly affected by BRD within the first 45 days after feedlot placement [4, 5]. 
According to the Feedlot 2011 study conducted by the National Animal Health 
Monitoring System (NAHMS), 97% of feedlots across the USA reported having 
cattle with BRD, and 16.2% of the cattle in a feedlot were affected by BRD dur-
ing the feeding period [6]. The annual financial loss attributed to BRD, including 
mortality, reduced feed efficiency and performance and treatment costs, has been 
estimated to be more than $4 billion to the US beef industry [7]. This loss surpasses 
the economic losses incurred by all other cattle diseases combined [8], given that 
BRD accounts for 70–80% of all morbidity and 40–50% of all mortality in the US 
feedlots [9].
Bovine respiratory disease is a complex disease with a multitude of stressors 
that predispose cattle to viral and bacterial infection. Mannheimia haemolytica, 
Pasteurella multocida, Histophilus somni and Mycoplasma bovis are the main bacterial 
pathogens involved in BRD and are, therefore, the main targets of antimicrobial 
treatments to control BRD [10]. In the North American feedlots, cattle considered 
at high risk for the development of clinical BRD signs are often given antimicrobial 
metaphylaxis upon feedlot arrival to prevent BRD [11]. However, recent studies 
have shown the emergence of BRD bacterial pathogens that are resistant to several 
classes of antibiotics used to both control and treat BRD [12–14]. The multidrug 
resistance in BRD pathogens towards particularly tilmicosin, tulathromycin and 
oxytetracycline has been increased in feedlot cattle in the last decade [15], and such 
increase may partially due to the increased use of these antibiotics as metaphylaxis. 
The continued rise in AMR in BRD bacterial pathogens necessitates the developing 
antimicrobial alternative approaches to mitigate bacterial pathogens associated with 
BRD in feedlot cattle. Recent research results suggest the potential use of probi-
otic and essential oil (EO) as antibiotic alternative approaches to mitigate bovine 
respiratory pathogens [16, 17]. The objective of this chapter is to provide a brief 
overview of pathogenesis of BRD, to review the current status of antimicrobial 
resistance in bacterial pathogens associated with BRD and to discuss the potential 
antimicrobial alternative strategies, including probiotic and EO approaches, to 
mitigate bovine respiratory pathogens in feedlot cattle.
2. Bovine respiratory disease (BRD)
2.1 Pathogenesis of BRD
2.1.1 Predisposing factors
Bovine respiratory disease, also known as a shipping fever, is a complex multi-
factorial disease because its onset depends on the interaction between number of 
factors including host, environment, management and viral and bacterial infec-
tious agents (Figure 1) [18]. The host factors predisposing cattle to BRD include 
age, body weight, immune status and genetics [18]. The age and body weight of 
the calves entering the feedlot are, in most cases, inversely correlated with disease 
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susceptibility to BRD during the feeding phase [19, 20]. Shipping is the leading 
environmental risk factor for BRD due to the fact that almost all cattle placed in 
the feedlot are transported from elsewhere. Transportation distance has a nega-
tive impact on the animal resistance to the development of BRD owing to the 
stress and body weight loss that occur during the transportation [18]. In addition, 
commingling with other cattle in sale barns is an important management fac-
tor predisposing cattle to BRD. Because sale barn cattle have greater exposure to 
pathogens and stress as a result of mixing with cattle from multiple sources, feedlot 
cattle purchased from sale barn are often at greater risk for BRD compared to the 
ones purchased directly from the farm or ranch. Of note, the host, environment 
and management factors discussed above are necessary but not always sufficient to 
cause pneumonia, and thus, additional predisposing factors, such as viral infection, 
are often necessary to produce bacterial pneumonia [18].
2.1.2 Viral agents
The most common viral agents associated with BRD include bovine herpes-
virus type 1 (BHV-1), parainfluenza-3 virus (PI3), bovine viral diarrhea virus 
(BVDV) and bovine respiratory syncytial virus (BRSV) [13]. These viral patho-
gens can induce primary infection with mild clinical signs of BRD and predis-
pose cattle to bacterial infection [18, 21]. Viral infection can impair the mucosal 
barrier and respiratory pathogen clearance, damage the lung parenchyma and 
suppress immune responses in cattle. Combined, the effects of viral infection 
facilitate the proliferation of opportunistic bacterial pathogens in the upper 
respiratory tract and translocation of these pathogens into the lung and cause 
infections to the compromised lung [21]. A recent human study suggested that 
respiratory viruses can also affect the structure and composition of nasal micro-
biota, which may be another way through which virus weakens host resistance to 
bacterial pathogens [22].
Figure 1. 
Schematic overview of the pathogenesis of bovine respiratory disease in cattle.
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The main bacterial pathogens associated with BRD are M. haemolytica, P. mul-
tocida, H. somni and M. bovis [10]. M. haemolytica is the principal bacterial agent of 
BRD and has a considerable economic impact on the North American feedlot indus-
try. It is a small, Gram-negative and facultative anaerobic bacterium that commonly 
exists as a part of nasopharyngeal and tonsillar crypt microbiota in healthy cattle 
and sheep [23]. To date, 12 different (1, 2, 5–9, 12–14 and 16–17) capsular serotypes 
have been identified within M. haemolytica [23]. Among these serotypes, serotype 1 
(S1), serotype 2 (S2) and serotype 6 (S6) are most frequently isolated from feedlot 
cattle, with the S1 and S6 being the most prevalent in bovine infection [24, 25]. 
M. haemolytica residing in the upper respiratory tract of healthy cattle maintains a 
commensal relationship with the host due to the containment by the local microbiota 
and host immunity [23]. However, when the local microbiota and host immunity get 
disrupted by stress and viral infections, this opportunistic bacterium proliferates 
in the upper respiratory tract and then translocates into the lung where it induces 
acute infection characteristics to fibrinous pneumonia [23]. M. haemolytica-induced 
pathogenesis is accomplished through a combination of virulence factors including 
outer membrane proteins, leukotoxin (Lkt), lipopolysaccharide (LPS) and lipopro-
teins [23]. The outer membrane proteins, such as adhesion protein, facilitate attach-
ment and colonization of M. haemolytica to the bovine respiratory cells. The Lkt, 
being the most important virulence factor, attracts neutrophils and macrophages 
to the site of infection when it is present in low concentration. High levels of Lkt, 
however, induce cell death of leukocytes and phagocytes, allowing M. haemolytica to 
evade the detection and destruction by the host immune system. The other virulent 
factors, including LPS and lipoproteins, are involved in hemorrhage, edema, hypox-
emia and acute inflammation [10]. The virulence factors of M. haemolytica differ 
among different serotypes, and such difference has been reported to attribute to the 
genetic differences among serotypes [25].
P. multocida and H. somni are also opportunistic BRD pathogens and are involved 
in the development of bronchopneumonia in cattle with clinical signs indistinguish-
able from pneumonia caused by M. haemolytica. The isolation rate of P. multocida 
and H. somni from clinically healthy cattle at feedlot entry is relatively high ranging 
from 15% up to 60% [10], suggesting they predominately exist as part of normal 
nasopharyngeal flora in healthy cattle. However, the isolation rate of these two 
pathogens is higher in the lower respiratory tract of feedlot cattle affected by BRD 
compared to healthy cattle [13]. The main virulence factors identified in  
P. multocida include a LPS, a cytotoxin, and iron acquisition proteins [10]. H. somni 
virulence factors include expression of immunoglobulin-binding proteins, survival 
in phagocytic cells, induction of apoptosis in endothelial cells, antigenic phase 
variation and endotoxic activity of the LPS and biofilm formation [10].
Compared to the other three BRD bacterial pathogens, M. bovis is the least 
characterized BRD pathogen. This bacterium lacks a cell wall and is fastidious, 
requiring specialized media and techniques for its isolation and culture. M. bovis 
is often associated with chronic pneumonia, and its mechanism of actions remains 
poorly understood [10].
2.2 Current prevention and control strategies for BRD in feedlots
Prevention and control of BRD in large commercial feedlots in North America 
are aimed mainly at bacterial pathogens, through the use of antimicrobials and vac-
cination programs. Cattle considered at high risk for the development of BRD are 
often given metaphylactic antimicrobials upon feedlot arrival [26]. Metaphylaxis 
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is defined as the mass treatment of an entire group or population of cattle with 
an antimicrobial to prevent and minimize an expected outbreak of disease [26]. 
Overall, 59.3% of feedlots in the USA with a capacity of >1000 head cattle use 
injective metaphylaxis, with approximately 21.3% of the cattle placed in the feedlot, 
receive metaphylactic antibiotics [6]. In Western Canada, more than 80% of the 
cattle in some feedlots receive injectable metaphylactic antibiotics on arrival to the 
feedlot (Personal communication with Dr. Steve Hendrick, Coaldale Vet Clinic, 
Alberta, Canada). The decision for metaphylactic intervention is primarily based 
on the nature of cattle population arriving at the feedlot. Cattle populations that 
are lighter body weight, multiple sources origin, and have poor health history and 
experienced long distance travel are often subjected to metaphylactic treatment 
at feedlot entry [26]. Metaphylactic treatment reduces BRD-associated morbidity 
and mortality by eradicating the already existing bacterial infections and prevent-
ing colonization and proliferation of pathogens in those immunosuppressed and 
vulnerable animals. Although efficacy of metaphylaxis to reduce BRD incidence in 
feedlots and subsequently improve cattle performance and carcass characteristics 
has been relatively well documented [26, 27], metaphylaxis is facing more and more 
public scrutiny due to the increased antimicrobial resistance in BRD pathogens, as 
well as increased public and scientific concerns regarding the overuse of antimicro-
bials in livestock production.
Bacterial vaccination is another common practice for the prevention of BRD in 
feedlot cattle in North America. There are a number of commercial vaccines available 
against M. haemolytica, P. multocida, H. somni and M. bovis [28]. These vaccines are 
made from bacterins or killed whole bacterium. Bacterial vaccines are less frequently 
used in feedlots compared to virus vaccines. This might be due to the controversial 
and limited efficacy of these vaccines against BRD bacterial pathogens [28].
2.3 Current challenges associated with BRD prevention: antimicrobial resistance
Despite advances in antimicrobials and vaccines, increased metaphylactic use 
and best management efforts to mitigate BRD, the prevalence of BRD in feedlot 
cattle continues to be increasing [9]. Although data are lacking, one contributor to 
increased BRD prevalence might be the development and spread of AMR in BRD 
pathogens. Recent studies have shown the emergence of BRD bacterial pathogens 
that are resistant to all classes of antibiotics used to treat BRD. For example,  
P. multocida strain isolated from a cow that died of BRD in Alberta has shown resis-
tance up to five different antibiotics commonly used to control BRD (Alexander lab, 
unpublished data). M. haemolytica isolates isolated from Canadian and the US feed-
lots also exhibited resistance to more than three antibiotics [12, 13, 29]. Multidrug-
resistant H. somni isolates have also been detected in Albertan feedlots [13].
The prevalence of multidrug-resistant BRD bacterial pathogens is relatively 
high and increasing in both Canadian and the US feedlots over the years [30]. A 
recent study conducted in commercial feedlots in Alberta, Canada, revealed that 
there were significantly high levels of resistance (>70%) against tulathromycin 
and oxytetracycline in M. haemolytica and P. multocida isolates and high levels of 
resistance against oxytetracycline (67%) and penicillin (52%) in H. somni isolates 
isolated from the lower respiratory tract of feedlot cattle with (n = 210) and without 
(n = 107) BRD [13]. Likewise, Anholt et al. [31] observed that 100% of the  
M. haemolytica (n = 233), P. multocida (n = 117) and M. bovis (n = 226) and 67% of 
the H. somni (n = 75) isolates isolated from both living and dead BRD-affected cat-
tle, originated from 60 different commercial feedlots in southern Alberta, exhibited 
resistance towards at least one antimicrobial class. Over 90% of all isolates (n = 745) 
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is defined as the mass treatment of an entire group or population of cattle with 
an antimicrobial to prevent and minimize an expected outbreak of disease [26]. 
Overall, 59.3% of feedlots in the USA with a capacity of >1000 head cattle use 
injective metaphylaxis, with approximately 21.3% of the cattle placed in the feedlot, 
receive metaphylactic antibiotics [6]. In Western Canada, more than 80% of the 
cattle in some feedlots receive injectable metaphylactic antibiotics on arrival to the 
feedlot (Personal communication with Dr. Steve Hendrick, Coaldale Vet Clinic, 
Alberta, Canada). The decision for metaphylactic intervention is primarily based 
on the nature of cattle population arriving at the feedlot. Cattle populations that 
are lighter body weight, multiple sources origin, and have poor health history and 
experienced long distance travel are often subjected to metaphylactic treatment 
at feedlot entry [26]. Metaphylactic treatment reduces BRD-associated morbidity 
and mortality by eradicating the already existing bacterial infections and prevent-
ing colonization and proliferation of pathogens in those immunosuppressed and 
vulnerable animals. Although efficacy of metaphylaxis to reduce BRD incidence in 
feedlots and subsequently improve cattle performance and carcass characteristics 
has been relatively well documented [26, 27], metaphylaxis is facing more and more 
public scrutiny due to the increased antimicrobial resistance in BRD pathogens, as 
well as increased public and scientific concerns regarding the overuse of antimicro-
bials in livestock production.
Bacterial vaccination is another common practice for the prevention of BRD in 
feedlot cattle in North America. There are a number of commercial vaccines available 
against M. haemolytica, P. multocida, H. somni and M. bovis [28]. These vaccines are 
made from bacterins or killed whole bacterium. Bacterial vaccines are less frequently 
used in feedlots compared to virus vaccines. This might be due to the controversial 
and limited efficacy of these vaccines against BRD bacterial pathogens [28].
2.3 Current challenges associated with BRD prevention: antimicrobial resistance
Despite advances in antimicrobials and vaccines, increased metaphylactic use 
and best management efforts to mitigate BRD, the prevalence of BRD in feedlot 
cattle continues to be increasing [9]. Although data are lacking, one contributor to 
increased BRD prevalence might be the development and spread of AMR in BRD 
pathogens. Recent studies have shown the emergence of BRD bacterial pathogens 
that are resistant to all classes of antibiotics used to treat BRD. For example,  
P. multocida strain isolated from a cow that died of BRD in Alberta has shown resis-
tance up to five different antibiotics commonly used to control BRD (Alexander lab, 
unpublished data). M. haemolytica isolates isolated from Canadian and the US feed-
lots also exhibited resistance to more than three antibiotics [12, 13, 29]. Multidrug-
resistant H. somni isolates have also been detected in Albertan feedlots [13].
The prevalence of multidrug-resistant BRD bacterial pathogens is relatively 
high and increasing in both Canadian and the US feedlots over the years [30]. A 
recent study conducted in commercial feedlots in Alberta, Canada, revealed that 
there were significantly high levels of resistance (>70%) against tulathromycin 
and oxytetracycline in M. haemolytica and P. multocida isolates and high levels of 
resistance against oxytetracycline (67%) and penicillin (52%) in H. somni isolates 
isolated from the lower respiratory tract of feedlot cattle with (n = 210) and without 
(n = 107) BRD [13]. Likewise, Anholt et al. [31] observed that 100% of the  
M. haemolytica (n = 233), P. multocida (n = 117) and M. bovis (n = 226) and 67% of 
the H. somni (n = 75) isolates isolated from both living and dead BRD-affected cat-
tle, originated from 60 different commercial feedlots in southern Alberta, exhibited 
resistance towards at least one antimicrobial class. Over 90% of all isolates (n = 745) 
displayed resistance to macrolide antimicrobials, which are the class of antibiotics 
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commonly used as metaphylaxis. Furthermore, Snyder et al. [14] also reported 
that a significant increase (from 3.7 to 99.2%) in the prevalence of M. haemolytica 
isolates resistant to tulathromycin in newly received feedlot cattle (n = 169) within 
2 weeks after tulathromycin was given as metaphylaxis.
Three or more resistant genes have been detected from M. haemolytica and  
P. multocida [15, 29]. These resistant genes are most likely occurring from de novo 
mutation or being acquired from other bacteria. It has been reported that some 
resistant genes present in BRD bacterial pathogens are being encoded in self-
transmissible conjugative elements [15]. Klima et al. [29] identified M. haemolytica, 
P. multocida and H. somni isolates from the US and Albertan feedlots that contain 
integrative conjugative elements (ICE) that conferred resistance up to seven dif-
ferent antimicrobial classes. These ICE can be transferred not only from one BRD 
pathogens to another BRD pathogen but also to other non-BRD-related bacteria 
(e.g. E. coli) via conjugation [29].
The resistant BRD-related pathogens can not only cause substantial profitability 
losses to the beef industry and animal welfare issues due to the higher disease 
relapse and mortality rate but also pose potential threat to the public health given 
the possibility of these transferable elements carrying resistant genes transfer into 
zoonotic pathogens. Therefore, counteracting measurements to reduce the develop-
ment and spread of AMR in BRD pathogens are urgently needed.
3. Alternative antimicrobial approaches to mitigate BRD bacterial 
pathogens
3.1 Probiotics
Probiotics are defined as “live microorganisms administered in adequate 
amounts that confer a beneficial health effect on the host” [32]. The scientific 
recognition of the health-promoting properties of live microbes began in the early 
1900s when a Ukrainian scientist, Elias Metchnikoff, hypothesized that the benefi-
cial microbes present in fermented milk could normalize bowel health and prolong 
life by inhibiting ‘putrefactive’ bacteria in the gut [32]. Then, lactic acid bacteria 
(LAB) strains isolated from fermented milk were commercialized with the inten-
tion to treat diarrhea in French children in 1906. The term probiotics has been used 
since 1962. In the past 2 decades, a significant research attention has been given to 
probiotics, and beneficial effects of probiotics for the mitigation of infections of 
oral cavity; respiratory, urogenital and gastrointestinal tract [33]; cancer [34] and 
obesity [35] have been identified.
Bacteria being used as probiotics today include LAB, non-pathogenic Escherichia 
coli and Bacilli [36]. The Lactobacilli and Bifidobacteria genera are the most com-
monly used as probiotics due to their specific health benefits, high safety profile, 
and stability [37, 38]. Probiotic bacterium possess unique genetic tools, special 
membrane structure and composition that allow them to survive under differ-
ent environmental conditions after ingestion, adhere to the target niche, adapt to 
special nutrition conditions and integrate with the local microbiota [37].
3.1.1 Mechanisms of probiotic action
Probiotics deliver their beneficial effects to the host through direct inhibition 
against potential pathogenic bacteria, improving the epithelial barrier function, 
stimulating the host immune system and re-establishing the commensal microbial 
community [37]. Probiotic bacteria can directly inhibit pathogens by producing 
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antimicrobial compounds such as lactic acid and bacteriocins. They can also prevent 
adherence of pathogenic bacteria to the host cells via competitive exclusion, as 
probiotic strains use the same binding sites as the pathogenic bacteria or downregu-
late the expression of pathogen-binding sites [37]. Probiotic Lactobacilli have also 
been reported to preserve intestinal epithelial barrier function through stimulating 
mucin secretion, strengthening tight junction and preventing epithelial cell death 
and thereby inhibit pathogen translocation [37].
In addition, probiotics have the potential to boost host immune defenses against 
pathogens by modulating immune response [39]. Probiotics regulate innate and 
adaptive immune response by modulating immune cells and cytokine production 
via toll-like receptor-regulated signaling pathways [40]. Probiotic-induced altera-
tions in the functions of dendritic cells, macrophages and T lymphocytes have been 
documented. For example, probiotic Lactobacillus strains modulated dendritic cells 
and thereby altered cell surface antigen expression and cytokine production in den-
dritic cells [37, 40]. Additionally, the impact of lactobacillus strains on macrophage 
function and its TNF-α production capacity has also been reported [41]. Probiotic 
bacteria L. acidophilus influenced the activity of regulatory T cells (Tregs) in vitro 
and in vivo in mice [42]. Tregs play a vital role in suppressing inflammation and 
maintaining immune tolerance.
Modulating the balance of pro- and anti-inflammatory cytokine production is 
one of the most important mechanisms through which probiotics protect the host 
from pathogen-induced injury and inflammation [43]. Probiotic bacteria have 
induced anti-inflammatory cytokine, IL-10, in dendritic and regulatory T cells 
[43]. IL-10, also known as the master regulator of immunity to infection, plays 
an essential role in facilitating the optimal pathogen clearance by inhibiting the 
activity of Th1 cells, NK cells and macrophages [44]. In addition, probiotics inhibit 
pro-inflammatory cytokine production and thereby prevent excessive inflamma-
tion. Probiotic strain L. rhamnosus GG inhibited the LPS-stimulated TNF-α produc-
tion in murine macrophages [45]. Also, L. rhamnosus GR-1 strain has significantly 
or partially reduced LPS-induced number of proinflammatory cytokines including 
TNF, IFN-γ, IL-1β, IL-2 and IL-6 in human decidual cells [46]. Of note, the immune 
modulation properties of probiotics are species- and strain-specific, and therefore, 
different species or different strains within a species are expected to have different 
immunomodulation properties [37].
The role of probiotics on the local microbiota starts to be better understood 
due to the completion of the human genome project and the development of next 
generation DNA sequencing platforms that enabled a deeper understanding of the 
structure and composition of the host microbiome. Studies suggest that probiotics 
may re-establish the composition of the gut microbiota and confer beneficial effects 
on the gut microbial communities [47, 48]. However, there is limited informa-
tion available with respect to the effects of probiotics on respiratory microbiota. 
A very recently published study showed that the oral probiotics alter respiratory 
microbiota of healthy cats [49]. The orally ingested probiotics were detected in 
the respiratory tract of the cat and were also associated with changes in richness 
and the overall composition of colonizing microbial populations of the respiratory 
tract. This observation points out that oral probiotics could alter the respiratory 
microbiota.
3.1.2 Using probiotics to mitigate BRD bacterial pathogens
Beneficial effects of probiotics in the prevention and control of human respira-
tory tract infections have been studied. For example, probiotic strain Streptococcus 
salivarius K12 can mitigate pharyngitis by inhibiting the colonization of pathogen 
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dritic cells [37, 40]. Additionally, the impact of lactobacillus strains on macrophage 
function and its TNF-α production capacity has also been reported [41]. Probiotic 
bacteria L. acidophilus influenced the activity of regulatory T cells (Tregs) in vitro 
and in vivo in mice [42]. Tregs play a vital role in suppressing inflammation and 
maintaining immune tolerance.
Modulating the balance of pro- and anti-inflammatory cytokine production is 
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from pathogen-induced injury and inflammation [43]. Probiotic bacteria have 
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due to the completion of the human genome project and the development of next 
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microbiota of healthy cats [49]. The orally ingested probiotics were detected in 
the respiratory tract of the cat and were also associated with changes in richness 
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Beneficial effects of probiotics in the prevention and control of human respira-
tory tract infections have been studied. For example, probiotic strain Streptococcus 
salivarius K12 can mitigate pharyngitis by inhibiting the colonization of pathogen 
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Streptococcus pyogenes and stimulating anti-inflammatory response in epithelial cells 
[50, 51]. A recent study revealed that the relative abundance of nasopharyngeal 
LAB in cattle entering the feedlot was significantly greater in animals that remained 
healthy compared with those that developed BRD [52], suggesting that a certain 
LAB are important to bovine respiratory mucosal health. Furthermore, an in vitro 
pilot study that we conducted to test antimicrobial properties of commercially 
available LAB strains (Lactobacillus) against M. haemolytica demonstrated the pos-
sibility of using probiotics to mitigate BRD pathogens [53]. The Lactobacillus strains 
isolated from the nasopharynx of healthy feedlot cattle displayed antimicrobial 
activity against the growth of M. haemolytica in vitro [54]. We also recently reported 
that the intranasal inoculation of Lactobacillus spp. strains inhibits the colonization 
of M. haemolytica S1 into the nasopharynx of dairy calves challenged with  
M. haemolytica S1 (Amat et al., unpublished data). These studies suggest the poten-
tial application of probiotics to mitigate BRD bacterial pathogens in feedlot cattle as 
an alternative to antimicrobial metaphylaxis.
3.2 Essential oils
Essential oils (EOs) from aromatic and medicinal plants are receiving increased 
scientific attention because of their long history of being sources of natural antimicro-
bial substances for the treatment of infectious diseases [55]. Thanks to their natural 
mixture of very complex chemical composition, EOs have shown a broad range of 
antimicrobial activities against both Gram-negative and Gram-positive bacterial 
pathogens and have long been used for respiratory tract infections (Figure 2) [56, 57]. 
For example, respiratory pathogens including Streptococcus pyogenes, S. pneumonia and 
Escherichia coli were effectively inhibited by EOs of cinnamon bark, thyme and spotted 
beebalm in vitro [58].
Interestingly, EOs exhibit minimal effects on LAB including Lactobacilli and 
Bifidobacteria that are commonly used as probiotics [59], suggesting EOs may have 
limited negative effects on beneficial bacteria within the host microbiota. The EOs 
showed higher minimal inhibition concentration (MIC) values for the probiotic 
bacteria, whereas it was effective in much lesser concentration against pathogenic 
bacteria in gastrointestinal tract [59]. Saguibo et al. [60] reported that some probi-
otic LAB have selective resistance against inhibitory effect of several plant extracts 
that displayed a strong inhibition on pathogenic bacteria. These evidences suggest 
the possible combination of the probiotics with EOs and combat with pathogenic 
bacteria. Probiotics accomplish their antimicrobial activities mainly through 
producing bacteriocin. In most cases, the probiotics inhibit proliferation of patho-
gens by generating acidic environment and thereby lower the chance of pathogens’ 
survival. EOs exhibit their antibacterial effect by inducing morphological changes 
in the target bacterial cells as well as producing reactive oxygen species (ROS) 
within the bacterial culture [58]. The EOs can accomplish a complete killing of the 
pathogens even at a lower dosage as the pathogens are normally lack of counteract-
ing mechanism against the effects of EOs [59]. Combining EOs with probiotics is 
expected to increase the efficacy of probiotics in controlling the bacterial pathogens 
owing to their synergistic effect which is normally higher than the two individual 
effects due to their complementary actions [61].
Immune stimulatory effects of EOs have also been well documented. EOs 
extracted from Eucalyptus globules stimulated the innate cell-mediated immune 
response [62]. Inhibition of cytokine production and arachidonic acid metabolism 
by a compound of eucalyptus EO has been observed in human blood monocytes 
in vitro [63]. The same authors also reported the anti-inflammatory effects 
of eucalyptus EO in bronchial asthma [64]. Likewise, vapors of EOs showed 
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anti-inflammatory effect on the trachea and reduced asthma [65]. In addition to the 
antimicrobial and immune modulation properties, the antibiotic resistance modify-
ing activity of EOs has recently been gaining research interest [66–68]. Some EOs 
and their major components, such as thymol and geraniol, have shown to improve 
the efficacy of antibiotics against multidrug-resistant bacterial pathogens and 
therefore have been suggested to be used as antibiotic adjuvants [67, 69, 70].
3.2.1 Using EOs to mitigate BRD bacterial pathogens
Although antimicrobial activity of EOs against human respiratory bacterial 
pathogens has been well documented, limited information is available with respect 
to the effects of EOs against bovine respiratory pathogens. We have recently pub-
lished data showing that EOs inhibit the BRD bacterial pathogens M. haemolytica,  
P. multocida and H. somni [16]. The EOs of ajowan, thyme and cinnamon leaf com-
pletely or partially inhibited these BRD pathogens in both vapor and liquid phases 
[16, 17]. These EOs did not display any noticeable cytotoxicity to bovine turbinate 
cells of the upper respiratory tract [17] and also exhibited minimal antimicrobial 
activity on six commensal Lactobacillus strains that were isolated from the nasal 
pharynx of a healthy feedlot cattle [17]. This suggests that EOs will have limited 
negative effects on the commensal bacterial community within the bovine respira-
tory tract, when they are administered to target pathogens. In addition, Kissels 
et al. [71] evaluated four different EO components, including carvacrol, thymol, 
transanethole and 1,8-cineole, as antibacterial agents or as adjuvants for the antibi-
otics doxycycline and tilmicosin against M. haemolytica and P. multocida. Carvacrol 
and thymol inhibited the growth of both of these tested pathogens with MIC values 
ranged from 0.63 to 2.50 mM. These two EO compounds also displayed an additive 
effect when one of them was combined with tilmicosin. In addition, combination of 
thymol with dexycycline displayed synergetic effect against tested BRD pathogens. 
These studies demonstrated that EOs can be used to control bovine respiratory 
pathogens in feedlot cattle. Volatile nature of EO makes the EO more promising 
Figure 2. 
The antibacterial properties of essential oils (EOs).
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therapy for the control of bovine respiratory pathogen in the upper respiratory tract 
as it makes suitable to intranasal administration via nasal spray [72]. However, fur-
ther research in terms of the effect of EOs on the respiratory commensal microbiota 
of cattle and the cytotoxicity of EOs on lower respiratory tract is needed.
4. Conclusions
The economic impacts of cattle disease on the beef cattle industry still remain 
significant, with BRD being the most significant health problem in modern feedlot 
industry in North America. The BRD is commonly associated with pneumonia 
in nursing beef calves and recently weaned feedlot cattle and often occurs within 
the first 45 days after feedlot placement. The BRD is considered as one of the most 
significant health problems in the beef industry accounting for economic losses 
that surpass those incurred by all other diseases of cattle combined. Treatment and 
control of BRD in the beef sector are aimed mainly at bacterial pathogens through 
antimicrobial use (therapeutic and non-therapeutic administration) and vaccina-
tion programs. However, recent studies have shown the emergence of bacterial 
pathogens associated with BRD that are resistant to all classes of antibiotics used 
to treat BRD. The increase in the multidrug resistance towards these antimicrobi-
als that are being used as metaphylaxis in feedlots necessitates the development 
of novel methods to mitigate bovine respiratory pathogens in feedlot cattle as 
alternatives to metaphylactic antimicrobial use. Probiotic and EOs, being two major 
natural antimicrobial sources, display the potential application of antimicrobial 
alternative agents against bovine respiratory bacterial pathogens. More research 
is needed to develop nasal-delivered probiotics or EOs that can inhibit pathogenic 
bacteria, with limited effects on commensals and respiratory tract, after intranasal 
administration.
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One Health Approach to Control 
Brucellosis in Sierra Leone
Roland Suluku, Jesse P.J. Nyandeboh and Sheku Moiforay
Abstract
Brucellosis is a febrile zoonotic disease that presents a severe hazard to humans 
and domestic animals, which requires a One Health approach to control socioeco-
nomic consequences and public health implications on the people in the country. 
The majority of the cattle owners are illiterate herds’ men with traditional 
knowledge of cattle management handed down by their ancestors. Management is 
free range with no supplementing or balanced diet. Access to veterinary services 
is almost not available, and local herdsmen treat their animals. Most of these 
herdsmen do not allow livestock officer visitors to have access to their animals. 
Processing of meat and milk uses traditional methods, and people consume fresh 
milk without due regard to sanitary conditions. This behavior has serious public 
health implications especially when the majority of the beneficiaries live in rural 
communities. Animals abort, while production decreases due to delayed concep-
tion. Local herdsmen confer confidence in people who are knowledgeable about 
cattle management. Researchers have no data on the disease in the last 50 years. 
Supportive action from various sectors such as human, animal and environmen-
tal health stakeholders backed by social anthropologists using the One Health 
Platform will provide a conducive atmosphere to engage herdsmen in initiating 
control measures of the disease.
Keywords: brucellosis, herdsmen, animals, community, One Health
1. Introduction
Brucellosis is a common contagious, communicable and One Health endemic 
zoonotic disease of public health significance with a high rate of morbidity and 
life sterility [1]. Brucellosis is named after Sir David Bruce because he isolated the 
causative agent from a soldier while working in Malta. The disease Malta fever or 
Mediterranean fever got it named when it affected British military personnel in 
1886. Malta fever is a fever condition occasionally caused by Brucella, and its most 
common species B. abortus and B. melitensis. B. abortus causes premature delivery in 
cattle and intermittent fever in human [2, 3].
1.1 Animals affected
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vi. B. neotomae—desert rat
The disease affects cattle, goat, sheep, pigs, buffaloes, camels and reindeer, and 
other animals may be less frequently affected. All the above diseases cause brucel-
losis, but of significance to man and animals worldwide are three species Brucella 
suis affecting pigs, Brucella melitensis affecting small ruminants and Brucella abortus 
affecting cattle. Brucella canis also affects dogs.
Recent research shows that Brucella causes pinnipedialis in seals and ceti sp. in 
whales [4].
1.2 Socioeconomic effect of brucellosis
Brucella causes abortion in pregnant cow or premature calving, death of 
young animals, birth of weak calves, stillbirth, delayed calving, sterility, 
retained placenta, male infertility followed by a decrease in milk yield [1, 5]. 
The death is due to mastitis and hygromas in African cattle. Vesiculitis, epididymis 
and orchitis are characteristic in the bull which sometimes leads to testicular 
abscesses, metritis and life infertility. In pregnant animals, a visible swelling of 
the mammary gland around the naval region followed by bleeding from the 
vagina is not common in pregnant animals infected with Brucella. Enlargement 
of the udder indicates a high level of bacteria in shredded milk, urine and vagina 
discharge.
1.3 Transmission of bovine brucellosis
1.3.1 Animal
Bacteria are excreted with the fetus, the placenta and uterine fluid during 
calving.
Animals’ discharge the organism after parturition, abortion or via milk of 
infected cow [6, 7].
Infected breeding bulls transmit infection via semen.
Vertical transmission is through calves or lamb in the uterus [1, 8].
Transmission can occur through contaminated water and feed.
1.3.2 Humans
Human brucellosis has different names based on the region in which the disease 
occurred. They named it Malta fever, because Dr. Bruce discovered the disease in 
this town, Cyprus or Mediterranean fever, rocky fever of Gibraltar, intermitted typhoid 
and undulant fever [9, 10].
Fever is a general symptom across all human patients. Uterus infection with 
fetal death accompanied by general malaise, fatigue and arthritis with chronic 
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and recurring febrility with joint pain are common in human beings [10, 11]. 
Chronic symptoms include loss of working day, high fever because of septicemia 
followed by emancipation, insomnia, headache, loss of appetite and sexual 
impotence in a human patient [12].
Human to human transmission occurs through transplacenta and breastfeeding 
but not through sexual intercourse, blood transfusion or transplantation of body 
organs [10, 13]. The disease is transmitted by direct contact with infected tissue 
or their products [10, 11]. Transmission by inhalation of an organism or into the 
conjunctiva occurs by air. In humans, transmission is not limited to the reproduc-
tive organs but the nervous system. It causes neurobrucellosis showing symptoms of 
meningitis, encephalitis, stroke, myelitis and neuropsychiatric features [14]. Brucellosis 
causes deafness as reported by other scientists [15].
1.4 Africa and Asia
Brucellosis is one of the most widespread bacterial zoonotic diseases in the 
world. It affects both humans and domestic and wild animals [16]. WHO reports 
about 500,000 cases of human brucellosis every year [17]. An economic impact 
assessment conducted in both Africa and Asia in 2013 by McDermott et al. [18] 
shows that the disease is endemic across Africa and Asia continents and responsible 
for most of the human cases. The disease worsens and deprives people in developing 
countries like sub-Saharan Africa of the much-needed protein. Poverty is a driv-
ing force of brucellosis especially in communities where people depend heavily on 
livestock for their livelihood [19].
Brucella subtype causes brucellosis in many parts of the world including West 
Africa. Brucella abortus biovar 3 is a common strain that affects cattle [20]. These 
West African isolates are mostly characterized from autochthonous cattle and 
hygroma fluid samples. Data are required to assess the potential threats of public 
health importance both at national and regional levels.
2. Brucellosis in Sierra Leone
Sierra Leone is located in the humid tropical forest in the west coast of West 
Africa. It is boarded by the Republic of Guinea in the north and north-west and 
Liberia in the south and southwest and by the Atlantic Ocean in the west. The 
country has five ecological zones: the Mangrove swamp, Savannah grassland, forest 
vegetation, inland valley swamp and Bolland and has nine significant rivers that 
retain water all year round.
The high natural vegetation provides a conducive environment for rearing 
animals such as ruminants. Ruminant production such as cattle is confined to the 
northern district of Koinadugu extending north-eastward to Kono District and 
southward to Bombali District. These three districts were known as the cattle belt of 
Sierra Leone. Major cattle markets exist in these districts.
Brucellosis outbreak occurred in Sierra Leone in 1966. The veterinary division 
mounted a campaign, which they divided into three phases, from 1966 to 1969. 
About 50% of herds became infected in Bombali and Kono, and cases of abortion 
were reported in Njala. Strain 19 has been used over the years, but the problem 
persists. A nationwide vaccination and DCIP Havac strain (45/20) were anticipated, 
but never materialized.
Most of the veterinary structures and institutions started degenerating during 
this period. The status of the disease remains unknown, but abortion and stillbirth 
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about 500,000 cases of human brucellosis every year [17]. An economic impact 
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shows that the disease is endemic across Africa and Asia continents and responsible 
for most of the human cases. The disease worsens and deprives people in developing 
countries like sub-Saharan Africa of the much-needed protein. Poverty is a driv-
ing force of brucellosis especially in communities where people depend heavily on 
livestock for their livelihood [19].
Brucella subtype causes brucellosis in many parts of the world including West 
Africa. Brucella abortus biovar 3 is a common strain that affects cattle [20]. These 
West African isolates are mostly characterized from autochthonous cattle and 
hygroma fluid samples. Data are required to assess the potential threats of public 
health importance both at national and regional levels.
2. Brucellosis in Sierra Leone
Sierra Leone is located in the humid tropical forest in the west coast of West 
Africa. It is boarded by the Republic of Guinea in the north and north-west and 
Liberia in the south and southwest and by the Atlantic Ocean in the west. The 
country has five ecological zones: the Mangrove swamp, Savannah grassland, forest 
vegetation, inland valley swamp and Bolland and has nine significant rivers that 
retain water all year round.
The high natural vegetation provides a conducive environment for rearing 
animals such as ruminants. Ruminant production such as cattle is confined to the 
northern district of Koinadugu extending north-eastward to Kono District and 
southward to Bombali District. These three districts were known as the cattle belt of 
Sierra Leone. Major cattle markets exist in these districts.
Brucellosis outbreak occurred in Sierra Leone in 1966. The veterinary division 
mounted a campaign, which they divided into three phases, from 1966 to 1969. 
About 50% of herds became infected in Bombali and Kono, and cases of abortion 
were reported in Njala. Strain 19 has been used over the years, but the problem 
persists. A nationwide vaccination and DCIP Havac strain (45/20) were anticipated, 
but never materialized.
Most of the veterinary structures and institutions started degenerating during 
this period. The status of the disease remains unknown, but abortion and stillbirth 
are common among ruminants throughout the country.
Bacterial Cattle Diseases
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Table 1 explains the increase and spread of cattle production from the north and 
east in 1966 [21] to every district in the country [22]. This spread of cattle production 
corresponds to an increase in the spread of brucellosis. The majority of cattle owners 
or herders are Fulani nomads with little or no formal education. Pastoral Fulani who 
own approximately 90% of the national herd [23] own cattle production.
The majority of the cattle owners practice a free-range animal production 
system, which encourages animals to move into large areas of land in search of food. 
Pastoralists utilize an extensive range of land as common pool resources through 
movement from one location to another making full use of their character and 
cultural practices [24]. In Nigeria, land use management is characterized by the 
transhumant system due to vegetation variations, agricultural practices and tsetse 
fly infestation [25]. Fulani pastoralists migrated to Hausa land from Senegalese 
valley in western Sudan but were forced to move due to deteriorating environmental 
conditions, land degradation and recurrent draught, thus accounting for the exodus 
to Guinea savannah to the forest fringes in the southern parts of Nigeria [26].
Illiteracy is a significant factor among cattle herds or agropastoralists exac-
erbating brucellosis or other cattle diseases in West Africa and Sierra Leone in 
particular. Cattle rearers or agropastoralists use knowledge passed onto them by 
Estimated number of livestock by type, district and region
Administrative units Type
Cattle Goat Sheep Pigs Chickens Ducks
District
Kailahun 430 54,478 17,159 6924 98,894 150
Kenema 5332 73,507 50,980 11,842 200,560 25,861
Kono 101,156 44,661 22,559 5455 65,599 3675
Bombali 158,705 61,723 51,831 8553 125,451 2623
Kambia 62,223 47,053 26,503 6278 171,903 3305
Koinadugu 97,858 63,327 39,136 38,214 137,045 630
Port Loko 11,614 97,596 52,737 4909 259,212 5436
Tonkolili 36,138 76,796 31,744 5047 115,903 2398
Bo 50,930 97,920 22,640 9086 173,037 10,493
Bonthe 6840 26,987 9161 9051 60,715 12,078
Moyamba 11,629 48,101 8499 5660 146,996 7606
Pujehun 3510 36,934 28,136 5265 86,335 8352
WAR&U** 514 83,822 66,581 101,213 314,981 17,167
Total 546,881 812,906 427,667 217,497 1,956,630 99,775
Region
Eastern 106,918 172,646 90,698 24,221 365,053 29,686
Northern 366,539 346,495 201,951 63,001 809,513 14,392
Southern 72,911 209,942 68,436 29,062 467,082 38,530
Western Area 514 83,822 66,581 101,214 314,981 17,168
Total 546,881 812,906 427,667 217,497 1,956,630 99,775
Source: [22]. **Western Area Rural & Urban.
Table 1. 
Projections for national livestock populations by species, by district and by region.
39
One Health Approach to Control Brucellosis in Sierra Leone
DOI: http://dx.doi.org/10.5772/intechopen.82378
their accentors. Studies conducted in northern Nigeria reported a common feature 
of rural farming, as about 42% of cattle rearers or agropastoralists are illiterate or 
had no formal education [27]. The majority of pastoralists (58%) had no western 
formal education compared to 66.2% who had acquired Islamic education [28]. As a 
result, they have no balanced diet prepared for their animals, nor supplementation 
of the ration. Kassam [29] opined that the livestock sector lacks adequate supplies 
of quality feed and pasture.
Animals became malnourished, emaciated and exposed to diseases. Compounding 
the situation further is the lack of adequate veterinary service to attend to the needed 
problems of the cattle herds. One of the main problems highlighted by cattle farm-
ers is the lack of poor veterinary services available in their communities [30]. Cattle 
farmers purchase drugs from foot peddlers to treat their animals. All the cattle 
ranches visited in Sierra Leone have drugs to treat their animals. Cattle farmers refuse 
government officials or livestock officer access to their animals.
Cattle milk is a significant source of brucellosis. When people pasteurize milk, 
they reduce human infection. Resource-limited or poor communities do not 
pasteurize milk due to their long-standing traditional beliefs and cultural practices 
and the complete lack of public health implications of raw milk consumption [31]. 
These food products from the informal sector escape formal health and safety 
practices, thereby increasing the spread of brucellosis to the general public [32].
3. How do we control brucellosis in Sierra Leone?
The strategy to prevent brucellosis is much dependent on the production system. 
Two methods used include test and slaughter and vaccination. The former requires 
a laboratory facility, which is lacking in the rural communities. The latter option 
involves not only the administration of vaccines but also many other techniques and 
includes various sectors of people.
A large percentage of the adult population in Sierra Leone is illiterate and live in 
rural communities where cattle farmers exist. Any change or transformation in the 
cattle sector to control brucellosis will require the involvement of the entire cattle 
rearers and the community people. This approach is known as One Health.
One Health approach is any benefit to the complete well-being of humans, 
animals and their environment because of the synergy of integrated humans, and 
veterinary is a positive step toward the One Health approach. Such vale can even 
include financial savings and environmental services [33].
The One Health approach involves the following:
i. Conducting a scoping mission to ascertain the prevalence and incidence of 
the disease in the community. It involves visiting communities where the 
disease has occurred and identifying stakeholders for future discussion 
on an agreed date based on their farming calendar. It also includes gaining 
knowledge about the sociocultural and traditional customs of the people in a 
defined community.
ii. Holding stakeholder meetings with animal rearers and owners including 
local administrative authorities in the community. In this forum, the scop-
ing team meets the local administration to tell them about the etiology and 
epidemiology of the disease, its mode of transmission, signs and symptoms 
and how to prevent and control. The local authorities will put a mechanism 
in place to ensure compliance by all people. This involves both animals’ own-
ers and community people, hence the One Health concept.
Bacterial Cattle Diseases
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to Guinea savannah to the forest fringes in the southern parts of Nigeria [26].
Illiteracy is a significant factor among cattle herds or agropastoralists exac-
erbating brucellosis or other cattle diseases in West Africa and Sierra Leone in 
particular. Cattle rearers or agropastoralists use knowledge passed onto them by 
Estimated number of livestock by type, district and region
Administrative units Type
Cattle Goat Sheep Pigs Chickens Ducks
District
Kailahun 430 54,478 17,159 6924 98,894 150
Kenema 5332 73,507 50,980 11,842 200,560 25,861
Kono 101,156 44,661 22,559 5455 65,599 3675
Bombali 158,705 61,723 51,831 8553 125,451 2623
Kambia 62,223 47,053 26,503 6278 171,903 3305
Koinadugu 97,858 63,327 39,136 38,214 137,045 630
Port Loko 11,614 97,596 52,737 4909 259,212 5436
Tonkolili 36,138 76,796 31,744 5047 115,903 2398
Bo 50,930 97,920 22,640 9086 173,037 10,493
Bonthe 6840 26,987 9161 9051 60,715 12,078
Moyamba 11,629 48,101 8499 5660 146,996 7606
Pujehun 3510 36,934 28,136 5265 86,335 8352
WAR&U** 514 83,822 66,581 101,213 314,981 17,167
Total 546,881 812,906 427,667 217,497 1,956,630 99,775
Region
Eastern 106,918 172,646 90,698 24,221 365,053 29,686
Northern 366,539 346,495 201,951 63,001 809,513 14,392
Southern 72,911 209,942 68,436 29,062 467,082 38,530
Western Area 514 83,822 66,581 101,214 314,981 17,168
Total 546,881 812,906 427,667 217,497 1,956,630 99,775
Source: [22]. **Western Area Rural & Urban.
Table 1. 
Projections for national livestock populations by species, by district and by region.
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their accentors. Studies conducted in northern Nigeria reported a common feature 
of rural farming, as about 42% of cattle rearers or agropastoralists are illiterate or 
had no formal education [27]. The majority of pastoralists (58%) had no western 
formal education compared to 66.2% who had acquired Islamic education [28]. As a 
result, they have no balanced diet prepared for their animals, nor supplementation 
of the ration. Kassam [29] opined that the livestock sector lacks adequate supplies 
of quality feed and pasture.
Animals became malnourished, emaciated and exposed to diseases. Compounding 
the situation further is the lack of adequate veterinary service to attend to the needed 
problems of the cattle herds. One of the main problems highlighted by cattle farm-
ers is the lack of poor veterinary services available in their communities [30]. Cattle 
farmers purchase drugs from foot peddlers to treat their animals. All the cattle 
ranches visited in Sierra Leone have drugs to treat their animals. Cattle farmers refuse 
government officials or livestock officer access to their animals.
Cattle milk is a significant source of brucellosis. When people pasteurize milk, 
they reduce human infection. Resource-limited or poor communities do not 
pasteurize milk due to their long-standing traditional beliefs and cultural practices 
and the complete lack of public health implications of raw milk consumption [31]. 
These food products from the informal sector escape formal health and safety 
practices, thereby increasing the spread of brucellosis to the general public [32].
3. How do we control brucellosis in Sierra Leone?
The strategy to prevent brucellosis is much dependent on the production system. 
Two methods used include test and slaughter and vaccination. The former requires 
a laboratory facility, which is lacking in the rural communities. The latter option 
involves not only the administration of vaccines but also many other techniques and 
includes various sectors of people.
A large percentage of the adult population in Sierra Leone is illiterate and live in 
rural communities where cattle farmers exist. Any change or transformation in the 
cattle sector to control brucellosis will require the involvement of the entire cattle 
rearers and the community people. This approach is known as One Health.
One Health approach is any benefit to the complete well-being of humans, 
animals and their environment because of the synergy of integrated humans, and 
veterinary is a positive step toward the One Health approach. Such vale can even 
include financial savings and environmental services [33].
The One Health approach involves the following:
i. Conducting a scoping mission to ascertain the prevalence and incidence of 
the disease in the community. It involves visiting communities where the 
disease has occurred and identifying stakeholders for future discussion 
on an agreed date based on their farming calendar. It also includes gaining 
knowledge about the sociocultural and traditional customs of the people in a 
defined community.
ii. Holding stakeholder meetings with animal rearers and owners including 
local administrative authorities in the community. In this forum, the scop-
ing team meets the local administration to tell them about the etiology and 
epidemiology of the disease, its mode of transmission, signs and symptoms 
and how to prevent and control. The local authorities will put a mechanism 
in place to ensure compliance by all people. This involves both animals’ own-
ers and community people, hence the One Health concept.
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iii. Engaging community people to identify control and preventive strategies, 
and ensuring that they understand the process. At this stage, the scoping 
team members ask community people about existing strategies they have 
used in the past and how do they intend to control and prevent subsequent 
outbreaks. Scoping team members equally provide alternative ways based 
on their experience to control and prevent the disease. Community people 
select those among various alternatives that suit their needs the most. Local 
authorities will now engage their people and animal owners to ensure that 
they understand the controlled strategy. Defaulters pay minimum fine 
proposed by all.
iv. Identifying the leading players in the prevention of brucellosis. In any com-
munity, some people can mobilize the people. Such people known as critical 
stakeholders command respect in the community; scoping team work with 
local authorities to identify such people, charge them with the responsibil-
ity of passing the message across the community and encourage people to 
implement the decision of the community in full.
v. Dividing the group into various units or components. Key stakeholders and 
scoping team members work together and spread the message in the com-
munity on the disease which includes the following:
• Print and electronic media. Identifying people within and outside the 
community to write about the disease and intervention by the commu-
nity people. Such interventions could be flyers on various aspects of the 
disease as an awareness-raising process strategy to inform the people and 
country as a whole.
• Play/drama committee: Identifying people within and outside the com-
munity, to act a play on brucellosis. Such play focuses mainly on how 
people contract the disease, signs and symptoms, mode of transmission, 
prevention and control. The drama target public health aspects of eating 
dead animals with the disease. Such interventions will educate the public 
and communities will put the disease under control.
• Songs: They composed songs in their local dialect as a means of under-
standing the disease correctly.
• Quiz committee for schoolchildren. Quiz competitions are held in vari-
ous schools where the outbreak has occurred; children pass the message 
to their parents and neighbors from the competitions held. Such actions 
will educate the general populace and help reduce or eradicate it from the 
community.
• Bike riders, taxi/poda poda drivers: These are a group or community of 
people who aid in killing and stealing of these animals in the community. 
Involving them in the awareness campaign and the implementation of the 
provisions of the by-laws will reduce stealing and minimize the spread of 
the disease. In such communities no bike rider transports animals after 
6:00 pm.
• Vaccination and registration committee. This committee is charged with 
the responsibility of educating the people and animal owners about 
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the need to vaccinate their animals. They mount such campaign for 
about a month or 2 weeks depending on the availability of funds. People 
bring their animals in large numbers during the vaccination exercise. 
People register their animals in order to track them during subsequent 
registration.
• Engaging the radio in massive sensitization and education about brucel-
losis. The 11 year old civil war made the majority of Sierra Leoneans 
learn to love to listen to the radio. Such a medium has been used to pass 
information to the broader public, while at the same time allows them 
to ask a question. The outbreak of disease has reduced due to increase in 
knowledge of the people on a particular disease.
vi. Formulating by-laws to ensure compliance by all categories of people and 
conducting routine vaccination on yearly basis. This bottom-top approach 
will help in the prevention of brucellosis in Sierra Leone.
vii. The above process benefits people by engaging them all in fighting disease 
outbreaks. Such gathering of people to fight the common enemy called 
disease is known as ONE HEALTH.
4. Conclusions
Brucellosis is a zoonotic disease ravaging resource-poor communities in the 
world including Africa and Asia. Vaccination campaigns in Sierra Leone had not 
eradicated the disease since 1966. The One Health approach which adds value to 
people’s lives by the involvement of all partners with a strong medium of communi-
cation is a step in the right direction toward controlling the disease in Sierra Leone.
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Abstract
Leptospirosis is a communicable disease at farms that results in abortion and 
pathological changes in animals and human respectively. Disease is majorly spread-
ing through indirect contact with contaminated urine material. The causative agent 
belongs to Leptospira genus having 21 species, 25 serogroups, and 250 serovars. The 
prevalence noted at world level is counted to be 41.39% with 30.11% in Asia, 25.62% 
in Africa, and 46.42% in South Africa. The virulence is attributed to Loa22 protein 
which is the first protein identified as essential virulence factor. Pathogenesis 
involves vasculitis following which are direct cytotoxicity and immunological injury 
resulting in renal failure. Direct examination, PCR, isothermal methods, micro-
scopic agglutination test (MAT) and IgM enzyme-linked immunosorbent assay 
(ELISA) are diagnostic approaches for leptospirosis. The MAT is a gold standard test 
for leptospirosis identification. Doxycycline and azithromycin were used as drugs 
against leptospirosis in mild and severe cases of leptospirosis. Further studies are 
needed regarding identification, treatment, and effective vaccination.
Keywords: leptospirosis, Leptospira, disease outbreaks, leptospirosis vaccine, 
Leptospira tests, epidemiology, prevalence
1. Introduction
Leptospirosis is a worldwide but more neglected zoonotic disease that usually 
affects humans and animals around the world [1–3] with case records 350,000 
annually [4]. Death occurs from 10 to 50% in severe infection cases [5]. Pathogenic 
Leptospira are bacteria that cause the disease through penetration into the mucous 
membrane or damaged skin of the host [6]and then transfer to the proximal tubule 
of the kidneys [7]. Infected animals remain asymptomatic and secrete infectious 
organisms in urine throughout their lifetime [8]. Leptospira are excreted in the urine 
for weeks, months, or longer [9]. It pollutes moist soil, farm land, and rivers. Infection 
occurs when a person or animal is in intimate contact with a contaminated climate or 
infected urine of host [6]. The famous Leptospira carriers are wild, domestic, and some 
other mammalian species [10]. Occurrence of leptospirosis in humans is also associ-
ated with high temperature, high humidity, and basic hygienic conditions [11, 12].  
Human leptospirosis is biphasic, with the general symptoms of pyrogens associated 
with acute or leptospiremic phase, continuing for about 1 week, and subsequent of 
Bacterial Cattle Diseases
44
study of Simbe, Zimbabwe. Livestock 
Research for Rural Development. 
2012;24:9
[31] Welburn SC, Beange I, Ducrotoy MJ, 
Okello AL. The neglected zoonoses—
The case for integrated control and 
advocacy. Clinical Microbiology and 
Infection. 2015;21(5):433-443. DOI: 
10.1016/j.cmi.2015.04.011
[32] Grace D. Food safety in low and 
middle-income countries. International 
Journal of Environmental Research and 
Public Health. 2015;12(9):10490-10507. 
DOI: 10.3390/ijerph120910490
[33] Zinsstag J et al. One Health Theory 
and Practice of Integrated Health 
Approach; Switzerland: Swiss Tropical 
and Public Health Institute; Herston, 
Australia: University of Queensland; 
Canada: University of Guelph. 1st 





Leptospirosis: Rising Nuisance for 
Cattle and Threat to Public Health
Amjad Islam Aqib, Muhammad Ijaz, Shahid Hussain Farooqi, 
Muhammad Shoaib, Muhammad Fakhar-e-Alam Kulyar  
and Khadija Yasmeen
Abstract
Leptospirosis is a communicable disease at farms that results in abortion and 
pathological changes in animals and human respectively. Disease is majorly spread-
ing through indirect contact with contaminated urine material. The causative agent 
belongs to Leptospira genus having 21 species, 25 serogroups, and 250 serovars. The 
prevalence noted at world level is counted to be 41.39% with 30.11% in Asia, 25.62% 
in Africa, and 46.42% in South Africa. The virulence is attributed to Loa22 protein 
which is the first protein identified as essential virulence factor. Pathogenesis 
involves vasculitis following which are direct cytotoxicity and immunological injury 
resulting in renal failure. Direct examination, PCR, isothermal methods, micro-
scopic agglutination test (MAT) and IgM enzyme-linked immunosorbent assay 
(ELISA) are diagnostic approaches for leptospirosis. The MAT is a gold standard test 
for leptospirosis identification. Doxycycline and azithromycin were used as drugs 
against leptospirosis in mild and severe cases of leptospirosis. Further studies are 
needed regarding identification, treatment, and effective vaccination.
Keywords: leptospirosis, Leptospira, disease outbreaks, leptospirosis vaccine, 
Leptospira tests, epidemiology, prevalence
1. Introduction
Leptospirosis is a worldwide but more neglected zoonotic disease that usually 
affects humans and animals around the world [1–3] with case records 350,000 
annually [4]. Death occurs from 10 to 50% in severe infection cases [5]. Pathogenic 
Leptospira are bacteria that cause the disease through penetration into the mucous 
membrane or damaged skin of the host [6]and then transfer to the proximal tubule 
of the kidneys [7]. Infected animals remain asymptomatic and secrete infectious 
organisms in urine throughout their lifetime [8]. Leptospira are excreted in the urine 
for weeks, months, or longer [9]. It pollutes moist soil, farm land, and rivers. Infection 
occurs when a person or animal is in intimate contact with a contaminated climate or 
infected urine of host [6]. The famous Leptospira carriers are wild, domestic, and some 
other mammalian species [10]. Occurrence of leptospirosis in humans is also associ-
ated with high temperature, high humidity, and basic hygienic conditions [11, 12].  
Human leptospirosis is biphasic, with the general symptoms of pyrogens associated 
with acute or leptospiremic phase, continuing for about 1 week, and subsequent of 
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recovery or immunization which is defined by antibody production [13]. In the past 
few decades, leptospirosis has become an infectious disease of urban environments 
especially in industrialized and developing countries. Rural areas are also affected 
with high mortality due to delay in diagnosis and lack of infrastructure with adequate 
clinical suspicion and other unknown causes like inherent pathogenicity of Leptospira 
strains [8]. Leptospirosis is very common in tropical and subtropical areas where 
people are very close to animals. Warm and humid environment favors in distribu-
tion and survival of pathogen [14]. Sporadic cases are reported throughout the year 
with incidence ranges from 0.1 to 10 per 100,000 people; and during the epidemic, 
it can reach over 50 per 10,000 people. Most cases are reported in Sri Lanka, India, 
Indonesia, Maldives, and Thailand. In the past, Sri Lanka (2008), Jakarta (2003), and 
Mumbai (2005) have been reported as epidemic areas of Southeast Asia [10]. The 
molecular classification of Leptospira in different species is described on DNA correla-
tion base [3, 15]. The genome of Leptospira consists of two round chromosomes whose 
entire sequence has been established recently [8, 16]. The genome is larger than the 
genomes of other spirochetes, which shows the viability of Leptospira in different harsh 
environments [17]. Symptoms usually appear suddenly after an incubation period of 
2–20 days, with a duration of 14 days at least. About 10% of patients diagnosed with 
leptospirosis having signs like Weil’s disease, which manifests itself as jaundice, kidney 
failure, and hemorrhagic in pulmonary arteries [18]. Leptospirosis is usually related to 
headache, fever with muscular pain in both adults and children. Drowsiness, vomiting, 
abdominal pain, diarrhea, cough, photophobia, arthralgia, and constipation may also 
occur [19].
2. Etiology
Leptospirosis is a prominent communicable disease caused by spirochete bacteria. 
The bacterial species belong to genus Leptospira that have ability to cause a disease in a 
variety of wild and domestic animal bases [3]. Spirochetes bacteria are motile having 
hook form or question-mark shape and range in size from 6 to 20 μm in length and 
0.1 μm in thickness [4]. Family Leptospiraceae includes genus Leptospira, which is fur-
ther divided into two strains, that is, pathogenic and saprophytic [4, 15]. Pathogenic 
Leptospira have 21 species, 25 serogroups, and 250 serovars [3, 5]. Leptospira spp. are 
obligate aerobes having sluggish growth. Ideal growth temperature for Leptospira is 
28–30°C [16]. There are different other characteristics of Leptospira like size, number 
of genes and pseudogenes, etc. (Figure 1). Serovars “pomona and grippotyphosa” are 
expectedly found to be the most prevalent candidates [17]. Leptospirosis in cattle is 
caused by Leptospira borgpetersenii and Leptospira interrogans serovar Hardjo, strains 
(well adapted to cattle) Hardjo bovis and Hardjo prajitno [18]. In Brazil as well as in 
Latin America, L. borgpetersenii serovar Hardjo strain Hardjo bovis were isolated from 
naturally infected cattle. Before this study, only serological studies had shown reactive 
animals with the serovar Hardjo in various countries [20, 21]. In Brazil, Chile, England, 
and Columbia, serovar Hardjo was found most prevalent among cattle [22]. Between 
1988 and 2007 in France, serovar Serjoe (34%) was most common in cattle [23]. There 
are different reservoir hosts of Leptospira (Table 1).
2.1 Prevalence of leptospirosis
Worldwide, the prevalence of animal leptospirosis is reported between 2 and 
46% depending upon animal species [12]. More than 15 serogroups of Leptospira 
is observed and isolated from cattle, for example, icterohaemorrhagiae, canicola, 
pomona and grippotyphosa, etc. (Rocha). Seroprevalence of different serovars 
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is different in all countries or regions. L. bratislava and L. grippotyphosa are more 
in Spain in those cattle which do not have good reproductive health [21]. Latin 
American countries, like Venezuela, have high prevalence of leptospirosis (80.51%) 
along with predominance of Sejroe serovar. Lesser incidence (2.6%) of disease 
has been observed in Peru during desiccated season when there are less chances 
for bacterial survival and transmission [24]. Similar results have been observed in 
Colombia and Mexico with the prevalence of 16.4–60.9% and 28.4–52%, respec-
tively [25, 26]. Particularly, in countries like India, the bovine leptospirosis is highly 
Figure 1. 
Main characteristics of pathogenic and trophic genome Leptospira spp. [20].
Reservoir host Serovar Reference
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prevalent, that is, up to 87% [27], 89.9% in Poland, and 88.2% in Mexico [28]. In 
contrary, certain states present lesser incidence, for example, 31.3% in Brazil [29], 
27.4% in Australia [30], 30.3% in Tanzania [31], 20.3% in Sri Lanka [32], and 19.1% 
in Iran [33] (Table 2). These variations could be due to altered topographical locali-
ties, husbandry and farm management applications, infection immunity among 
diverse rears, and intensities of normal resistance [29]. In urban areas, leptospirosis 
is broadly prevalent, as stated by Platts-Mills [34].
3. Pathogenesis
Leptospirosis is termed as “storm of abortion” and is farm economy jeopardiz-
ing malaise [42]. Leptospira spread in direct and indirect ways, while the latter 
is a more pronounced method of transfer. Direct transmission involves through 
infected urine, post abortion uterine discharge, sexual contact, and infected 
placentae. Indirect involves contact with environment. Bacteria get entry to skin 
through abraded skin that follows hematogenous spread in the body. Bacteria result 
vasculitis that in turn results into either direct cytotoxic injury and immunological 
reactions or massive migration of fluid from intravascular to interstitial compart-
ment. The latter results in renal dysfunction and vascular injury to internal organs. 
Pathogenic Leptospira could not be phagocytosed by macrophages and neutrophils, 
but if there are specific antibodies present, it can be phagocytosed [22]. It has been 
suggested that the animals are susceptible to severe or acute leptospirosis caused 
by increase in production of anti-inflammatory cytokines and chemokines [23]. 
Although pathogenic Leptospira are complementary to bactericidal activity, it has 
long been known that Leptospira has antimicrobial activity [43]. In most studies, 
leptospiral proteins that bind to one or more components are usually identified in 
recombinant form. Adhesin LenA (LfhA, Lsa 24) and Len B also bind to comple-
mentary regulatory protein factor H [44, 45]. Complement resistance to pathogenic 
Leptospira can also bind to the complement module C4BP, which catalyzes the 
cleavage of C4b [24]. It leads to decrease in surface deposition of subsequent com-
ponents of the complement, where decaying species are not available. In subsequent 
studies, this activity was attributed to the new leptospiral proteins LcpA and Lsa30 
[46]. Interestingly, ligand proteins that interact with many host ECM hosts and 
other proteins also interact with the complement regulators H, FHL-1, FHR1, and  
C4BP [25]. Surprisingly, the Leptospira elongation factor Tu shows a superficial 
effect and interaction with factor H, as well as binding to many purified host pro-
teins, which leads to its diversity, the so-called “moonlighting protein” [25]. Most of 
the above studies provide indirect evidence of the role of Leptospira protein in the 
prevention of complement, but recently, it has been shown that the pathogenicity 
and non-urogenital fecundity of the three complement pathways, including factor B 
[26]. C2 and C4b are identified in the culture supernatant of the Leptospira cleav-
age component. In fact, inactivation of the above two proteins, Lig B and Len B, 
does not have a significant effect on pathogenicity [27, 28, 47]. Similarly, functional 
redundancy must also be considered: LenA and LenB. All proteins have structural 
and functional similarities to the endostatin of mammals [44].
3.1 Known virulence factors
The emergence of the mutagenesis system revealed a small number of 
Leptospira genes that encode the components necessary for the manifestation 
of pathogenicity. The first leptospiral protein, identified as virulence, is Loa 
22, and the outer membrane protein containing the C-terminal OmpA domain 
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appears to mediate the connection between the outer membrane and the pepti-
doglycan layer (mutant hama loa 22). The presence of a homolog of Loa 22 in L. 
biflexa has an indirect effect on pathogenicity. Since lipopolysaccharide (LPS) 
is a pathogenic factor for all Gram-negative bacteria, it is not surprising that 
this hypothesis cannot be obtained until a certain mutant is identified in the 
Leptospira, studies eliminate motility by inactivating flagellated structures or 
genes involved in biosynthesis. Inactivation of fliY-encoding choleretic switch-
ing protein reduces toxicity in guinea pigs [29]. Mutations in the gene encoding 
the sensory protein LB139 reduce motility and down-regulation of a number of 
chemotactic genes and weaken the mutant for hamsters [30]. The lack of similar 
genes in vegetative bacilli strongly suggests the survival of mammalian species as 
well as in nutrition intake. Indeed, studies have shown toxicity related activities 
of Leptospira sphingomyelinase such as pore formation and cytotoxicity [31]. 
However, the key role of leptospiral sphingomyelinase in the pathogenesis is not 
genetically established. Recently, it has been shown that Leptospira-LruA [48] 
plays an important role in autoimmune response, which is associated with mam-
malian apolipoprotein A1 [49].
4. Transmission
Transmission of Leptospira occurs often with direct contact with infected urine, 
placenta, or milk. Transmission through venereal or transplacental route is also 
possible, whereas the most common route is infected urine. If there are leptospiral 
infected animals present in a dairy farm, the environment is also contaminated. 
Dairy feeder calves are probably the largest carriers of Leptospira in commercial 
feed yards. Dairy calves have the habit of sucking the scrotum of other calves in 
the pen, so this would be direct contamination of infected urine from carriers by 
suckling habit. Leptospira survives in the moist, damp, and moderately  
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Infection occurred by pathogenic leptospires is divided into two stages, first 
stage is acute stage or septicaemia (because septicaemia is in this stage), which lasts 
from 7 to 10 days with headache and myalgia. The second stage is immune stage 
which is after first week of infection and lasts 4–30 days [34]. During first stage, 
leptospires are present in blood and can say bacterial count is high in the blood, 
while when second stage starts, then the level of antibodies IgM and IgG start to 
increase and this increase in antibodies titer is correlated to elimination of lepto-
spires from blood. Leptospira antigens and DNA sometimes may not be detected 
from the blood; this may be due to late sampling, or sampling in acute stage where 
proper level of leptospiremia is not developed and due to antibiotic administration, 
leptospires are eliminated from the blood. False negative results will be there, if we 
detect antibodies prior to sero-conversion during acute stage. Coagulated blood has 
serum and clot while non-coagulated blood has plasma, RBCs, WBCs and platelets. 
That can be collected according to the tests. If you are going to do gene amplifica-
tion than EDTA, plasma gives the best results [50]. Leptospires can be detected in 
urine and cerebrospinal fluid samples. Many kits are available in the market for 
rapid detection of leptospires from blood, urine, and CSF sample; these kits basi-
cally detect nucleic acid of leptospires, but for these tests, purification of nucleic 
acid is required [51].
5.1 Current tools and emerging technologies for diagnosis of Leptospira
Different tools are being developed for the study of virulence factors, pathogenic-
ity, and basic cell biology of organisms [52]. These are essential for proper treatment 
and reduction of the severity of the disease. During acute infection, nonspecific 
symptoms of leptospires mimic the febrile condition, which are essential for proper 
treatment and reduce the severity of the disease. Therefore, the diagnosis of lepto-
spirosis is highly dependent on the particular laboratory tests [13]. Serology is the 
dominant one in diagnosis, while the micro-aggregation test (MAT) is the standard 
serological reference method. MAT is a sensitive test due to the antigenic heterogene-
ity of Leptospira, which require a large number of serovars as antigens. Furthermore, 
it is useless at early stage of the disease when antibodies are not present or present in 
less quantity [18]. Detection of disease in early stage helps the epidemiological inves-
tigators. However, antigen detection at this stage is more expensive and complex [13]. 
Current diagnostic tools for Leptospira detections other than MAT are rapid antibody-
based tests, direct examination of blood, the rapid nucleic-acid diagnosis, [53], dark 
field microscopy (DFM), IgM ELISA, and polymerase chain reaction (PCR) [13].
5.1.1 Direct examination
This method is cheap, but for direct examination, dark field microscope is required 
[54]. Theoretically, leptospires may be diagnosed by direct examination of blood 
during first week after onset of symptoms. Leptospires are 6–20 μm long and their 
diameter is 0.15 μm. Because of their size, dark field microscopy is required; 10−2–10−6 
leptospires/mL of blood may be observed during the acute stage of leptospirosis [55].
5.1.2 Gene amplification
5.1.2.1 PCR
The use of PCR is increasing in recent years and it has replaced the serological 
methods in endemic areas, because it is more sensitive and has capacity to give early 
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diagnosis. Real-time PCR is faster than regular PCR [56]. The threshold level in the 
urine or blood is 10–100 leptospires/mL (Figures 3 and 4) [50, 57].
5.1.2.2 Isothermal methods
In recent years, many isothermal amplification techniques are developed 
like isothermal technique [59]. This technique can be used as alternative to the 
PCR. There is no need for constant maintenance of temperature at 60–65°C and no 
thermal recycler is required; so, these things make it best for developing countries. 
Figure 3. 
Specificity of different diagnostic tests during acute phase of leptospirosis [56, 58].
Figure 4. 
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diagnosis. Real-time PCR is faster than regular PCR [56]. The threshold level in the 
urine or blood is 10–100 leptospires/mL (Figures 3 and 4) [50, 57].
5.1.2.2 Isothermal methods
In recent years, many isothermal amplification techniques are developed 
like isothermal technique [59]. This technique can be used as alternative to the 
PCR. There is no need for constant maintenance of temperature at 60–65°C and no 
thermal recycler is required; so, these things make it best for developing countries. 
Figure 3. 
Specificity of different diagnostic tests during acute phase of leptospirosis [56, 58].
Figure 4. 
Sensitivity of different diagnostic tests during acute phase of leptospirosis [58].
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For this, an effective and specific amplification is performed by DNA polymerase 
and six primers in 1 hour under isothermal conditions. Now the amplified DNA can 
be easily detected by eye observation of fluorescence without using gel electropho-
resis [60]. Loop-mediated isothermal amplification (LAMP) methods are recently 
developed for the quick diagnosis of pathogenic leptospires, and lipL41 and rrs are 
the genes targeted by LAMP. The specificity of these methods is weak because these 
can detect the threshold between 2 and 100 leptospires/reactive mixture [61].
5.1.3 Serological tests
5.1.3.1 The microscopic agglutination test (MAT)
This microscopic agglutination test is developed in Pasteur Institute. Dark field 
microscopy is required to see agglutination of live leptospires cultures with patient’s 
serum. This is the gold standard test for leptospirosis. It determines the anti-Lep-
tospira immunoglobulin titers in human and animal serum at the serogroup level, 
so it is used for clinical and epidemiological investigations [62]. MAT is performed 
on micro titration plates, dilutions of serum which is collected from the patient is 
made and then equal volume of leptospiral culture is added to form agglutinations 
of distinctive patterns that consist of highly dense packs of partly intact leptospires. 
The test is read by DFM.
5.1.3.2 IgM enzyme-linked immunosorbent assay (ELISA)
Normal ELISA is commonly used to diagnose leptospirosis. Enzyme immunoassay 
of leptospirosis can be performed using a commercially available kit or antigen obtained 
internally. Which is commonly used to detect IgM, and sometimes to detect IgG anti-
bodies against leptospiral antigens. The presence of IgM antibodies indicates current or 
recent leptospirosis. The commercially available Leptospira IgM ELISA is used for the 
serological detection of acute leptospirosis infection in a patient’s serum sample. This 
ELISA is based on the principle that any Leptospira IgM antibody present in the patient’s 
serum binds to the Leptospira antigen that adheres to the microporous surface of the 
microwell. Residual serum was removed from these wells by washing with 1% buffer 
(included in the kit). Peroxidase-conjugated anti-human IgM is presented after adding 
to the wells, and the plate is reincubated so that the bound antigen-antibody complex 
binds to the conjugate. The wells are washed again and a colorless substrate system, 
tetramethylbenzidine hydroperoxide, is added. The substrate is hydrolyzed, and the 
chromogen is blue. When the reaction is stopped with phosphoric acid, TMB turns 
yellow. The development of color indicates the presence of visual acuity IgM antibody 
against Leptospira in serum samples [63].
6. Necropsy findings
Cows with acute leptospirosis are characterized by anemia, jaundice, hemo-
globinuria, and lower lobe hemorrhage. An ulcer and bleeding may be present on 
the mucous membrane of the peritoneum. Pulmonary edema and emphysema are 
also common in cattle. Histologically, there is a progressive and diffuse interstitial 
nephritis and liver necrosis in the centre of the lobules. Sometimes the vascular 
lesions of the meninges are transferred to chronic infections. Leptospira can be 
seen in the silvery spots of a part of tortuous tubules proximal to the kidneys. In 
acute infection, there is minimal inflammation, and in the middle of the leaflet, 
there are only tubes filled with hemoglobin and visible liver necrosis. At a later 
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stage, progressive interstitial nephritis is characterized by a small white cortical 
lesion, which initially slightly increases or decreases with increasing age of the 
lesion. The fruit of a broken cow is usually automated by the fact that there is no 
damage or bacteria. Even fresh fruit, positive identification of leptospirosis in 
lesions is not easy. Although the use of fluorescent antibody technology facilitates 
the identification of organisms, false positive results are common unless expe-
rienced diagnosticians interpret the test. Although dark field microscopy can be 
attempted, it is not suitable for tissue collected at dissection. Although PCR tech-
nology is important, in some cases, several primer sequences may be required.
Samples for confirmation of diagnosis are kidney, liver and placenta. Histology 
of kidney, liver, brain, heart, lungs and placenta can be performed. While for 
serological analysis heart blood serum or pericardial fluid from foetus can also be 
obtained.
The zoonotic potential of this organism should keep in mind during handling of 
carcasses and submitting specimens.
7. Treatment
Treatment is based on severity of illness being presented by animal which in 
most of the cases is mild and self-limiting requiring no care. Other considerations, 
while treatment is considered, include differential diagnosis, cost, and availability 
of drugs. Treatment obtained based on in-vitro studies presented doxycycline, 
ampicillin, azithromycin or amoxicillin [64]. The double-blind randomized tri-
als conducted on 29 patients produced promising results by reducing symptoms 
of malaise in 2 days preventing leptospiremia. The treatment, however, was not 
conclusive prevention from progression to severity [65]. Doxycycline or azithromy-
cin is the drug of choice in endemic areas while contraindicated in pregnancy [64]. 
Sever cases are responsive to penicillin G sodium in studies conducted before 90s. 
The emerging resistance has narrowed spectrum of antibiotic use against infections 
[66]. Open randomized trial conducted with experiment involving 256 patients 
proved nonsignificant difference among penicillin G, cefotaxime, and doxycycline 
antibiotics [67]. Some of meta-analysis studies have reported nonsignificant differ-
ence between penicillin G and placebo on mortality [68]. Mortality is reported to 
increase up to 70% with pulmonary involvement which is due to immune-mediated 
inflammatory response. The therapeutic indicated for this complication is steroidal 
drugs. Early steroid administration was found responsive but methodologically 
flawed in various studies. Desmopressin was evaluated in various randomized 
studies as adjunct therapy with nonsignificant mortality benefits [69]. Therapy is 
considered beneficial with doxycycline or azithromycin along with steroid adminis-
tration in mild and severe cases. Variations in studies are reported with nonsignifi-
cant benefits to mortality reduction.
7.1 Blood transfusion
Leptospirosis is a zoonosis with worldwide distribution. It is more prevalent in 
the developing countries. Hemorrhagic manifestations constitute the common clini-
cal feature in leptospirosis [70]. In cattle, acute hemolytic syndrome of leptospirosis 
has been reported characterized by fever, icterus, anemia, and hemoglobinuria [71]. 
Without effective treatment, hemolytic syndrome in cattle may result in death. A 
high mortality rate of severe disease was determined to be associated with certain 
serotypes of Leptospira [72]. The disease, for instance, causes a decrease in erythro-
cyte and platelet counts, leading to anemia and hemorrhagic diathesis, respectively. 
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stage, progressive interstitial nephritis is characterized by a small white cortical 
lesion, which initially slightly increases or decreases with increasing age of the 
lesion. The fruit of a broken cow is usually automated by the fact that there is no 
damage or bacteria. Even fresh fruit, positive identification of leptospirosis in 
lesions is not easy. Although the use of fluorescent antibody technology facilitates 
the identification of organisms, false positive results are common unless expe-
rienced diagnosticians interpret the test. Although dark field microscopy can be 
attempted, it is not suitable for tissue collected at dissection. Although PCR tech-
nology is important, in some cases, several primer sequences may be required.
Samples for confirmation of diagnosis are kidney, liver and placenta. Histology 
of kidney, liver, brain, heart, lungs and placenta can be performed. While for 
serological analysis heart blood serum or pericardial fluid from foetus can also be 
obtained.
The zoonotic potential of this organism should keep in mind during handling of 
carcasses and submitting specimens.
7. Treatment
Treatment is based on severity of illness being presented by animal which in 
most of the cases is mild and self-limiting requiring no care. Other considerations, 
while treatment is considered, include differential diagnosis, cost, and availability 
of drugs. Treatment obtained based on in-vitro studies presented doxycycline, 
ampicillin, azithromycin or amoxicillin [64]. The double-blind randomized tri-
als conducted on 29 patients produced promising results by reducing symptoms 
of malaise in 2 days preventing leptospiremia. The treatment, however, was not 
conclusive prevention from progression to severity [65]. Doxycycline or azithromy-
cin is the drug of choice in endemic areas while contraindicated in pregnancy [64]. 
Sever cases are responsive to penicillin G sodium in studies conducted before 90s. 
The emerging resistance has narrowed spectrum of antibiotic use against infections 
[66]. Open randomized trial conducted with experiment involving 256 patients 
proved nonsignificant difference among penicillin G, cefotaxime, and doxycycline 
antibiotics [67]. Some of meta-analysis studies have reported nonsignificant differ-
ence between penicillin G and placebo on mortality [68]. Mortality is reported to 
increase up to 70% with pulmonary involvement which is due to immune-mediated 
inflammatory response. The therapeutic indicated for this complication is steroidal 
drugs. Early steroid administration was found responsive but methodologically 
flawed in various studies. Desmopressin was evaluated in various randomized 
studies as adjunct therapy with nonsignificant mortality benefits [69]. Therapy is 
considered beneficial with doxycycline or azithromycin along with steroid adminis-
tration in mild and severe cases. Variations in studies are reported with nonsignifi-
cant benefits to mortality reduction.
7.1 Blood transfusion
Leptospirosis is a zoonosis with worldwide distribution. It is more prevalent in 
the developing countries. Hemorrhagic manifestations constitute the common clini-
cal feature in leptospirosis [70]. In cattle, acute hemolytic syndrome of leptospirosis 
has been reported characterized by fever, icterus, anemia, and hemoglobinuria [71]. 
Without effective treatment, hemolytic syndrome in cattle may result in death. A 
high mortality rate of severe disease was determined to be associated with certain 
serotypes of Leptospira [72]. The disease, for instance, causes a decrease in erythro-
cyte and platelet counts, leading to anemia and hemorrhagic diathesis, respectively. 
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Elevated bilirubin levels result from hemolysis and hepatorenal failure, indicating 
the characteristic nature of clinical signs [73]. Blood transfusion was reported to be 
quite effective in cases of life-threatening anemia in cattle. Previous reports suggest 
that timely transfusion of whole fresh blood be administrated to overcome severe 
hemolytic leptospirosis. Indeed, transfusion providing the vital components such as 
erythrocytes, platelets, and plasma contributes to repair the present collapses, that 
is, anemia, hemorrhagic diathesis, septicemia, and hepatorenal failure, in affected 
cattle [71]. A PCV value of 15% or less developing acutely may require transfusion, 
while chronic anemia can be tolerated in cattle without any transfusion [74].
7.2 Vaccination
The optimal control regime for leptospirosis is to prevent clinical disease and 
exfoliation in the urine in animals exposed to different serotypes of Leptospira. The 
most common method of controlling leptospirosis in cattle is vaccination and selec-
tive treatment. In addition, proper quarantine procedures should be implemented to 
prevent the introduction of hajo in the herd by buying infected animals. However, 
leptospirosis and wild animals gave rise as a carrier of the prevalence of serotypes 
of hardjo infections in cattle, mainly to prevent the overall impact of leptospirosis 
in most dairy products and Rieben beef failure. This is impossible. Thus, vaccina-
tion depends on an increase in the resistance of an animal to leptospiral serotype 
infection in this area. In all cases, the effort (buildings, under the control of rodents 
around swamps and creeks, for example, surround) must be made in order to limit 
direct and indirect contact between the cattle and Leptospirosetragern. In addition, 
proper quarantine procedures should be implemented to prevent the introduction of 
hajo in the herd by buying infected animals. However, leptospirosis and wild animals 
gave rise as a carrier of the prevalence of serotypes of hardjo infections in cattle, 
mainly to prevent the overall impact of leptospirosis in most dairy products and 
Rieben beef failure. This is impossible. Thus, vaccination depends on an increase in 
the resistance of an animal to leptospiral serotype infection in this area. The leptoral 
vaccine currently available for cattle in the United States is a 5-fold bacterial whole 
cell vaccine, including Pomona, Canicola, Icterohaemorrhagiae, Grippotyphosa, and 
Hardjo serotypes. These antigens can also be used in various combinations of other 
viral and bacterial vaccines. In the United States, a series of experimental studies 
and field data are available from the United States. Typical leptospirosis vaccines are 
Hajo kidney serotype infection, urinary tract infection or fetus (ha-ha type). This 
does not exclude the fact that the state indicates that the country is isolated from the 
United States. Many of the available Hardjo vaccines were approved many years ago 
in rigorous efficacy studies that mimic the natural route of exposure, and the last 
method to determine whether the Hardjo serotypes are infected with cattle is Hardjo 
stocks which did not use the serotype. However, recently two Hardjo vaccine sero-
types have been widely studied using appropriate strains and methods. Compared 
to many other Hardjo serotype vaccines, these two products have shown excellent 
protection against infection and Hardjo hemoglobin isolation [75].
8. Conclusion
Leptospirosis is a major zoonotic disease resulting in high mortality in humans 
and animals. The disease is diagnosed clinically by fever, headache, vomiting, 
abdominal pain, and arthralgia. Leptospirosis is caused by more than 250 serovars, 
while pomona and grippotyphosa being the most prevalent serovars among them. 
However, among cattle, serovar Hardjo is the most important in causation of 
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disease. Among the Asian countries, the highest prevalence of leptospirosis was 
found in India. Leptospirosis is mainly transmitted by direct contact with infected 
urine, and bacteria are mainly entered through ruptured skin. In house IgM ELISA 
is highly specific technique for Leptospira diagnosis. However, among the sero-
logical test, ELISA is more sensitive test for Leptospira diagnosis. Most effective 
treatment for Leptospira is doxycycline or azithromycin; however, former is not 
recommended in pregnancy. However, in severe cases, blood transfusion is also a 
best choice to save the life of animal. At last, the most effective way to control the 
disease is vaccination at early age of life following booster doses to avoid from more 
severe economic losses.
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Tuberculosis is an infectious, chronic or acute, localized or disseminated gran-
ulomatous disease that affects all animal species, caused by members of the genus
mycobacteria. In cattle, the disease is caused by obligatory pathogenic and oppor-
tunistic species of mycobacteria and is transmitted between animals mainly
through inhalation. It is a major public health concern and humans are infected
chiefly through consumption of raw animal products. The disease is characterized
by progressive emaciation, which may be terminally fatal. Pathological lesions
comprising of be caseous or calcified granulomas are found mainly in the respira-
tory tract but animals infected through ingestion develop lesions in the lymph
nodes of the head and the mesentery. Lesions may disseminate to involve other
internal organs and tissues. Histologically, lesions manifest typical granulomas
with a necrotic center surrounded by inflammatory cells and a fibrous capsule.
Diagnosis is based on history, clinical signs, antemortem tests, and postmortem
examination. Culture, isolation, and identification of the organism are confirma-
tory tests. The disease is a listed under the OIE Terrestrial Animal Health Code and
the main method of control is testing and slaughter of affected animals. The
importance of the disease is the zoonosis, loss in productivity in affected animals,
and the cost of control.
Keywords: bacterial diseases, cattle, mycobacteria
1. Introduction
Tuberculosis in cattle is of serious public health as well as economic concern
worldwide but more so in developing world. The disease is a zoonosis, transmitted
from animals to humans mainly through the consumption of raw animal products
especially milk. Human infections are therefore prevalent in communities with poor
food hygiene and unsanitary cultural practices [1]. The resultant disease manifesta-
tion is largely similar to the human-type tuberculosis, with socioeconomic costs of
stigma, reduced productivity, mortality, and cost of treatment. Rigorous control
and eradication programs have drastically reduced transmission to humans in the
developed world but in the developing world, it remains a serious threat to human
health. Animal to animal transmission is mainly through the inhalation of infective
respiratory aerosols. Production systems that involve close contact between animals
promote transmission. The disease is listed under World Animal Health Organiza-
tion (OIE) and therefore a restriction to trade in animals and animal products.
Other costs include reduced animal productivity and the cost of control.
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Since its identification in 1898, Mycobacterium bovis (later split into two
subspecies: M. bovis subsp. bovis and M. bovis subsp. caprae) has been consid-
ered as the etiological agent of tuberculosis but later, other members of the
Mycobacterium tuberculosis complex (MTBC) were found to cause similar infec-
tions [2–4]. More recently, species of mycobacteria hitherto regarded as sapro-
phytic and nonpathogenic, referred to as nontuberculous mycobacteria (NTM)
and more recently, mycobacteria other than tuberculosis (MOTTs) have been
identified as causative agents [4, 5]. Apart from the requirement for isolation
and identification of the causative for confirmatory diagnosis, these species
have complicated interpretation of in vivo diagnostic tests, such as the tuber-
culin test, due to the expected cross-reactive immune responses [6, 7]. Some of
these MOTTs have also been found to cause a variety of infections in humans
and should therefore be considered potentially as zoonotic, and infestations in
cattle and other animals as important and the MTBC. Many other species of
animals are also susceptible to M. bovis. These include wildlife species, which
constitute reservoirs of infection for domestic animals [8, 9]. Transmission to
domestic animals and humans is therefore potentially an outcome of human-
wildlife conflict. With such a variety of mycobacteria species, now associated
with tuberculosis in cattle, perhaps the etiological term mycobacteriosis, rather
than the pathological term tuberculosis, should be more applicable. This chapter
will explore the etiology, epidemiology, pathogenesis, pathology, diagnosis,
public health importance, and control of tuberculosis in cattle. It is expected
that the chapter will be found useful by veterinary students, tutors, animal
health service providers, and researchers.
2. Definition
Tuberculosis is an infectious, chronic or acute, localized or disseminated
granulomatous disease that affects mammals, fish, and birds, caused by mem-
bers of the genus Mycobacterium. In cattle, the disease is caused by obligatory
pathogenic and opportunistic species of mycobacteria. Animals affected by the
disseminated infection progressively emaciate and finally succumb to the infec-
tion. The importance of the disease is its zoonosis and the economic losses
it causes.
3. History
Tuberculosis affects warm- and cold-blooded animals and it is estimated that it
has been around for more than 3 million years [10]. The disease in cattle was first
observed by the Spaniard farmer, Lucius Junius Moderatus Columella in Northern
Italy in the year 14 AD [11]. In 1881, Robert Koch discovered Mycobacterium
tuberculosis (tubercle bacillus) as the cause of tuberculosis in humans and in 1882,
established the connection between human and animal tuberculosis through the
observation that consumption of contaminated cow’s milk led to infection. In
1898, Theobald Smith identifiedM. bovis as a different species from M. tuberculosis.
The first compulsory milk pasteurization law was enacted in UK in 1908
following the research that linked consumption of raw milk to extrapulmonary
tuberculosis; two French scientists Albert Calmette and Camille Guerin developed
the Bacillus Calmette-Guerin (BCG) vaccine for immunizing humans against
tuberculosis, by attenuating M. bovis through subculture. The vaccine was first
used in 1921 [12]. In 1890, Robert Koch extracted tuberculin from the tubercle
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bacilli. The extract was initially tried as a vaccine, but later shown to have diagnos-
tic potential to detect infected animals. The tuberculin skin test for animals was
thereafter developed [10]. The development of the skin test for humans was then
carried out by Von Pirquet and Mantoux in 1907–1908 [13]. In the developed world,
bovine TB eradication programs involving herd testing and culling of reactors
and pasteurization of milk has largely eliminated the spread of bovine TB. The
disease, however, remains a serious public health problem in many developing
countries [14].
4. Etiology
4.1 Classification of mycobacteria
The genus Mycobacterium is the only genus in the family Mycobacteraceae in
the order Actinomycetales, which includes other mycolic acid-containing genera,
namely Nocadia, Rhodococcus, Gordonia, and Tsukamurlla. Currently, the genus
comprises of over 150 species and 13 subspecies [15, 16]. Within the genus,
classification is based on several factors including growth rate and pathogenic-
ity. Based on pathogenicity, it can be classified into two groups: tuberculous and
nontuberculous mycobacteria, the latter also referred to as mycobacteria other
than tuberculosis (MOTTs). A refined classification on this basis groups the
genus into obligatory pathogens, potentially pathogenic (opportunistic) and
saprophytic or ubiquitous microorganisms [17]. Obligatory pathogens belong to
Mycobacterium tuberculosis complex (MTBC) group that comprise Mycobacterium
bovis subsp. bovis, M. bovis subsp. caprae, M. tuberculosis, M. africanum, M. bovis
BCG, M. canetti, M. microtti, M. pinnipedii, and M. leprae [18]. All MTBC
species have identical 16S rRNA sequences and a 99.9% similarity at nucleotide
level, and may even be considered subspecies, but differ significantly in their
host range [19]. The potentially pathogenic mycobacteria, represented by the
Mycobacterium avium complex (MAC), consists of closely related species and
subspecies, which include, among others, M. avium subsp. avium, M. avium
subsp. paratuberculosis, and M. avium subsp. hominissuis. The potentially patho-
genic species are found in the environment as well as in the susceptible hosts
and cause disease mainly in hosts with compromised immunity [20]. Sapro-
phytic mycobacteria are the largest group found in the environment. Some,
such as M. kansasii, M. asiaticum, M. interjectum, M. szulgai, M. fortuitum,
M. celatum, M. ulcerans, M. smegmatis, and M. septicum have been associated
with diseases in humans and animals [21].
On the basis of growth rate, the genus is classified into slow and rapidly
growing species, with rapid-growers being those that produce grossly visible
colonies in less than 7 days and slow-growers taking over 7 days. Slow-growing
species are more commonly associated with pathogenicity than the fast-growing
group [22].
In cattle and other ruminants, tuberculosis is caused mainly by the obligate
pathogen Mycobacterium bovis subsp. bovis but infections by Mycobacterium bovis
subsp. caprae, Mycobacterium tuberculosis and Mycobacterium africanum also occur
[2–4]. In Central Europe,M. bovis subsp. caprae is the major cause of tuberculosis in
cattle [23, 24]. The disease caused by M. bovis subsp. bovis and M. bovis subsp.
caprae is commonly referred to as bovine or zoonotic tuberculosis. Although not as
widely as zoonotic tuberculosis, MOTTs infections have been reported in cattle
exhibiting granulomatous lesions identical to those caused by the MTBC complex
[6, 15, 16].
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4.2 Cellular morphology and staining
Mycobacteria are nonmotile, noncapsulating, and nonspore forming rods
measuring 0.2–0.6 μm by 1.0–10 μm with a slender, straight or slightly curved
shape. The cell wall of mycobacteria contains a hydrophobic lipid layer, which
includes mycolic acids, phosphatidylinositol, mannosides, phthiocerol
dimycocerosates, isoprenoid lipids, glycerophospholipids, lipoarabinomannan,
and trehalose mycolates and lipoglycans, which give the organism some unique
characteristics:
1. Growth requires complex organic media, containing long-chain free fatty acids
necessary for the synthesis of the lipid layer.
2. The hydrophobic lipid layer causes poor penetration of nutrients, hence
the slow growth of the organism and the long incubation period of
disease.
3. The poor penetration of chemical agents makes the organism difficult to stain
by ordinary procedures. Once stained, they resist decolorization even by
weak mineral acids such as 3% hydrochloric acid in ethanol, hence the name
acid-fast bacilli (AFB). Mycobacteria have a cell wall structure characteristic
of Gram-positive bacteria but they cannot be stained by this method although
they may stain weakly Gram-positive.
4.The organism is highly resistant to disinfectants and most antibiotics,
occasioning lengthy treatment of infection.
5. The presence of fatty acids in the cell wall causes cells to aggregate in a pattern
referred to as “cording,” observed in stained smears and in broth cultures, due
to resemblance to strands of rope cords, and in solid media, growth resembles
that of fungi (myco = Greek = means “fungus”).
6.The lipid layer plays a role in resistance to the host’s immune system [25–27].
Paradoxically, the biosynthesis site of some of the lipid components is also the
site of action of anti-TB drugs [26].
4.3 Cultural characteristics
Mycobacteria are obligate aerobes and require complex organic media for
growth. Solid media such as the egg-based Lowenstein-Jensen, (L-J),
Middlebrook 7H10, and Middlebrook 7H11 or liquid media such as Modified
Middlebrook 7H9 broth are used. Like other MTBC members, M. bovis is a slow
grower. On solid media, colonies are detectable 3–6 and up to 12 weeks of
incubation at 37°C weeks depending on the concentration of inoculum [28].
Colonies are small, raised, rounded, off-white (bluff) in color, wrinkled surface,
and with irregular margins [29]. Addition of pyruvate is reported to stimulate
growth of M. bovis and glycerol, which favors growth of M. tuberculosis, is said
to inhibit it [28, 30]. Other findings however, indicate that M. bovis can grow
satisfactorily in media containing either substance [5]. Members of MTBC
group, including M. bovis, are inhibited by paranitrobenzoic acid (PNB), a
criteria used to differentiate the group from MOTTs [31, 32]. Growth in liquid
media is faster since the organism is surrounded by the media and access to
nutrients is more efficient. Growth appears as clumps or “cords.” Addition of
egg yolk to the growth medium enhances growth, due to the presence of
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phospholipids that are required for growth but synthetic phospholipids such as
polyoxyethylene sorbate compounds (Tweens) can also be used, which also
lower the tendency of the mycobacteria to aggregate, giving a diffuse homoge-
nous turbidity [33].
4.4 Biochemical properties
M. bovis exhibits strain variation in biochemical characteristics, which can be
summarized as follows [28, 34, 35]:
Test Reaction
M. bovis M. tuberculosis
Sensitivity to thiophen-2-carboxylic acid hydrazide (TCH) + —
Sensitivity isonicotinic acid hydrazide (INH) + +
Niacin production — +
Nitrate reduction — +
Pyrazinamidase test +* —
Nicotinamidase test +* —
Amidase test — +
Urease production + Variable
Growth under microaerophilic environment + —
*Mycobacterium bovis subsp. caprae is negative.
The main limitation of biochemical tests is that sufficient amounts of bacterial
cells as well and several weeks of incubation are required. The other limitation is
that unknown species of mycobacteria cannot be identified. The availability of more
rapid methods such as molecular methods has therefore diminished the use of
biochemical tests.
4.5 Environmental, chemical, and drug resistance
In general, mycobacteria are inactivated by prolonged exposure to heat, direct
sunlight, and dry conditions. They are killed by temperatures of 65°C and above
for at least 30 minutes and UV light but are resistant to freezing for prolonged
periods. Under ordinary temperatures, M. bovis can persist in slurry and soil for at
least 6 months and can survive for long periods in buildings and transport vehicles
under dark, cold, and moist conditions [29, 36, 37]. The high lipid and wax
content makes mycobacteria less susceptible to many chemical agents and disin-
fectants. Chemicals such as quaternary ammonium compounds, hexachlorophene,
and chlorhexidine have bacteriostatic effect while formaldehyde vapor, chlorine
compounds, 70% ethanol, hydrogen peroxide alkaline glutaraldehyde, and 5%
phenol have bactericidal effect. Although treatment of infected animals is not
normally practiced, M. bovis is resistant to most antibiotics but sensitive to the
drugs used in treatment of M. tuberculosis (rifampin, isoniazid, streptomycin
(STR), and ethambutol). M. bovis subsp. bovis is resistant to pyrazinamide (PZA),
a first-line TB treatment drug in humans [38]. This characteristic is relevant in the
management of infection in humans and also useful in differentiating M. bovis
from M. tuberculosis. Multi-drug resistant strains of M. bovis have been reported in
many countries [39].
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5. Epidemiology of bovine tuberculosis
5.1 Host range
Mycobacteria have one of the widest host range and affects mammal, birds, fish,
reptiles, and amphibians. Cattle and related ruminants such as buffalo and bison are
regarded as the main hosts of M. bovis subspecies. Other mammalian hosts include
sheep, goats, camels, horses, llamas, pigs, dogs, cats, humans, and nonhuman pri-
mates [40]. Many wild animals, including elephants, rhinoceroses, coyotes, mink,
otters, seals, sea lions, hares, bears, warthogs, large cats ferrets, and rodents are
affected. Known maintenance hosts include possums and ferrets in New Zealand;
badgers, raccoons, and foxes in Europe; bison and elk in Canada; and kudu and
African buffalo in Africa and white-tailed deer in the USA [9].
5.2 Geographical distribution and prevalence
Zoonotic tuberculosis caused by M. bovis has a worldwide distribution. It was
reported by 78 of the 181 OIE reporting countries in 2017, distributed in every
region of the world [41]. This figure is likely to be much lower due to under-
reporting, occasioned by inadequate surveillance. Globally, the prevalence has been
estimated at 0.8% [42]. Using reports of zoonotic tuberculosis in humans as indica-
tion, the highest prevalence is found in African region followed by South East Asia,
Western pacific, Eastern Mediterranean, Europe, and lastly Americas [43]. The
disease has been largely controlled in developed world through systematic test and
slaughter of infected animals, meat inspection surveillance in abattoirs, and milk
pasteurization but complete eradication has been hindered by the existence of
reservoirs of the agent in wildlife species [44]. In many developing countries, the
disease remains largely neglected [45]. MOTTs have mainly been isolated coinci-
dentally from animal lesions while searching for M. bovis. Isolation of MOOTs from
cattle carcasses range approximately between 7 and 70% of total isolates [4, 5].
5.3 Transmission and risk factors
Infected animals shedMycobacterium via respiratory aerosols, milk, saliva, feces,
urine, and discharging lesions. The main route of infection in cattle is mainly
through the inhalation of infective aerosols. This is supported by high frequency of
tuberculous lesions found in the respiratory tract and associated lymph nodes [46].
Transmission is facilitated by close contact between animals and therefore the
production system plays an important role. Intensive livestock farming, referred to
as zero-grazing, promotes close contact between animals. In extensive production,
such as practiced by nomadic pastoralists in arid and semiarid regions of Africa,
close contact between animals occur in, night shelters, watering points, vaccination
centers, marketing yards, and at dipping tanks while in intensive production close
contact occurs during milking and in watering and feeding troughs [36]. Ingestion
of contaminated feed and water is generally considered to be a secondary, less
important route of transmission but in countries where untreated manure is com-
monly used as a fertilizer in farms, such manure can become a source of infection to
animals through pasture and vegetation contamination [36, 37]. The oral route is
also particularly important in calves nursing from infected cows.
Other rare routes of infection include cutaneous, genital during coitus, congen-
ital through placental or umbilical infection, and transmission through udder
infections [47]. Contact between domestic and wild animals through pasture con-
tamination is a risk factor. Domestic species reported to be reservoirs and spill-over
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hosts include sheep and goats. The low prevalence of tuberculosis in these species in
the African region, however, indicates that they may not be significant in transmis-
sion of disease to cattle [48, 49].
Human to animal transmission through aerosols is well documented and patients
with pulmonary tuberculosis pose danger to animals [50]. Humans with urogenital
tuberculosis represent a source of infection for animals through contamination of
pastures with urine. In Ethiopia, the traditional practice of spiting chewed tobacco
into mouths of livestock as anti-parasitic treatment is a potential source of infection
with M. tuberculosis [3].
Male animals were more significantly affected by than female animals while Bos
indicus (zebu) have been found to be more resistant than Bos Taurus (Exotic
breeds). At the herd level, herd size increases infection due to increased exposure
and introduction of new animals into a herd is a risk factor [51].
The primary source of infection by MOTTs is presumably the environment
[16], and although, the specific source of individual infections may not be easily
identified, and the route of infection may be deduced from the localization of
granulomas.
6. Pathogenesis
Animals exposed by ingestion of contaminated feed or water often develop
primary foci in lymph nodes associated with the intestinal tract, while aerosol
exposure leads to the involvement of the lungs and associated lymph nodes. In case
of respiratory infection, the mucociliary clearance in the upper respiratory passages
may prevent infection in some exposed animals [52]. In the bronchi, the organism
penetrates the mucosa and are trapped and phagocytosed in the bronchial and
mediastinal lymph nodes. In the lungs, the bacterial are phagocytosed by alveolar
macrophages. In case of oral infection, the organism presumably penetrates the
bucal or intestinal mucosa and, via the lymphatics, reaches the phagocytes in the
draining lymph node. The phagocytosis causes a localized inflammatory reaction
and recruitment of mononuclear cells from neighboring blood vessels. The cellular
response results in the accumulation of large number of phagocytes leading to the
formation of the granuloma or the tubercle that characterizes the disease [36, 47].
The granuloma consists of infected macrophages surrounded by epithelioid cells,
granulocytes, lymphocytes, and later, multinucleated giant cells [53].
Mycobacteria are facultative intracellular pathogens, and survive and multiply
within the hosts’ phagocyte. The ability of the organism to survive intracellular
within macrophages involves interfering with the development of the phagosome
into a degradative vesicle. It is thought that the organism prevents the phagosome
from maturing and fusing with lysosomes to form the phagolysosome. The mycolic
acids of the organism are thought to play a role in blocking this phagosome matu-
ration [54, 55]. Some components of the lipid layer, such trehalose dimycolate, may
cause death of macrophages by direct cytotoxicity [52]. TheMycobacterium survival
and multiplication within the phagosomes eventually destroys the macrophage.
When entering into the death phase, infected macrophages release mycobacterial
antigens, which are engulfed by uninfected dendritic cells, processed and subse-
quently presented, via major histocompatibility complex class I, to CD8+ T cells.
The cellular hypersensitivity that develops, contributes to cell death and tissue
destruction resulting in caseous necrosis. In some instances, liquefaction and cavity
formation occur as a result of enzymatic action on proteins and lipids, and the
organism multiplies uncontrolled in these cavities. Rapture of the cavities into the
bronchi allows aerosol spread of the bacilli. Dissemination by bacteria-containing
macrophage may occur through vascular and lymphatic channels to form lesions
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in many organs, as in acute miliary TB, which is rapidly fatal [47, 53]. Innate non-
specific and specific cell-mediated immunities are the main host defense
mechanisms. The innate resistance may clear the initial infection and prevent
mycobacteria to proliferate. Specific resistance is mediated by T-lymphocytes. They
destroy infected macrophages or activate them to destroy extracellular bacilli
through soluble mediators such as gamma interferon [56]. Where the host has
been able to contain spread of infection, lesions consistency progress from caseous,
fibro-caseous, fibro-calcified to calcified and are surrounded by a fibrous capsule.
Calcified granulomas generally indicate a successful suppression of the infection by
the immune response and the lesions may regress completely [53]. During patho-
logical processes, mycobacteria are present in tuberculous tissue and in various
body fluids, secretions and excretions such as milk, blood, sputum, bronchoalveolar
lavages, cerebrospinal fluid, and semen [36].
7. Pathology
Pathology of tuberculosis is characterized by the formation of granulomatous
lesions mainly in the respiratory and alimentary tracts and associated lymph nodes.
Figure 1.
Multiple tuberculosis lesions observed in lungs (A), pleura (B), mesentery (C) and diaphragm (D) in cattle
during postmortem meat inspection.
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The lesions may be localized to few organs or tissues or disseminated to multiple sites.
In the respiratory system, lesions are observed in bronchial lymph nodes, in lungs
(Figure 1A) and in mediastinal lymph nodes (Figure 2). The alimentary system
lesions involve the retropharyngeal, parotid, sub-maxillary, and mesenteric lymph
nodes (Figure 1C), as well as the liver and portal lymph nodes, the spleen and other
internal organs such as the kidneys [28]. Lesions may also be found on surfaces of
body cavities such as the pleura (Figure 1B), diaphragm (Figure 1D), and perito-
neum. In most cases, lesions are confined to the lymph nodes of the head region and
respiratory tract [47]. The size, color, and consistency of the lesions vary widely
according to the stage of infection. Lesion sizes are microscopic or large enough to
involve the greater part of or the whole organ or tissue. The consistency ranges from
caseopurulent, fibro-caseous fibro-calcified to calcified, but may also be thin-walled
purulent cavities [4, 5, 53]. Histopathological features of a granuloma show a central
area of caseous necrosis with or without calcification, surrounded by macrophages,
lymphocytes, plasma cells, neutrophils, epithelioid cells, and Langhan’s giant cells and
enclosed partially or completely by a fibrous capsule [53].
8. Clinical signs
The signs of tuberculosis in cattle usually vary depending on the organ systems
affected. In the early stages, clinical signs are not visible and many animals with
tuberculosis are clinically normal. The signs have a gradual onset characterized by
progressive weakness, debility, and mild fluctuating fever. Advanced lung involve-
ment is characterized by dyspnea, chronic moist cough, more marked in the morn-
ing and during cold weather, and reduced exercise tolerance [14]. Swollen lymph
nodes of the head may be observed and involvement of internal lymph nodes may
result in obstruction signs of the system or organ affected. There may be diarrhea or
constipation due gastrointestinal tract involvement. Mammary tuberculosis has
been found in varying proportions of animals, from 1 to 2%, up to 5.4% and is
characterized by persistent mastitis and hypertrophy [40]. Infertility or abortion
may result from tuberculous metritis, accompanied by chronic purulent vaginal
Figure 2.
Tuberculous lesions in the mediastinal lymph nodes of a goat meat carcass. ©2018. JKN Kuria.
71
Diseases Caused by Bacteria in Cattle: Tuberculosis
DOI: http://dx.doi.org/10.5772/intechopen.82051
in many organs, as in acute miliary TB, which is rapidly fatal [47, 53]. Innate non-
specific and specific cell-mediated immunities are the main host defense
mechanisms. The innate resistance may clear the initial infection and prevent
mycobacteria to proliferate. Specific resistance is mediated by T-lymphocytes. They
destroy infected macrophages or activate them to destroy extracellular bacilli
through soluble mediators such as gamma interferon [56]. Where the host has
been able to contain spread of infection, lesions consistency progress from caseous,
fibro-caseous, fibro-calcified to calcified and are surrounded by a fibrous capsule.
Calcified granulomas generally indicate a successful suppression of the infection by
the immune response and the lesions may regress completely [53]. During patho-
logical processes, mycobacteria are present in tuberculous tissue and in various
body fluids, secretions and excretions such as milk, blood, sputum, bronchoalveolar
lavages, cerebrospinal fluid, and semen [36].
7. Pathology
Pathology of tuberculosis is characterized by the formation of granulomatous
lesions mainly in the respiratory and alimentary tracts and associated lymph nodes.
Figure 1.
Multiple tuberculosis lesions observed in lungs (A), pleura (B), mesentery (C) and diaphragm (D) in cattle
during postmortem meat inspection.
70
Bacterial Cattle Diseases
The lesions may be localized to few organs or tissues or disseminated to multiple sites.
In the respiratory system, lesions are observed in bronchial lymph nodes, in lungs
(Figure 1A) and in mediastinal lymph nodes (Figure 2). The alimentary system
lesions involve the retropharyngeal, parotid, sub-maxillary, and mesenteric lymph
nodes (Figure 1C), as well as the liver and portal lymph nodes, the spleen and other
internal organs such as the kidneys [28]. Lesions may also be found on surfaces of
body cavities such as the pleura (Figure 1B), diaphragm (Figure 1D), and perito-
neum. In most cases, lesions are confined to the lymph nodes of the head region and
respiratory tract [47]. The size, color, and consistency of the lesions vary widely
according to the stage of infection. Lesion sizes are microscopic or large enough to
involve the greater part of or the whole organ or tissue. The consistency ranges from
caseopurulent, fibro-caseous fibro-calcified to calcified, but may also be thin-walled
purulent cavities [4, 5, 53]. Histopathological features of a granuloma show a central
area of caseous necrosis with or without calcification, surrounded by macrophages,
lymphocytes, plasma cells, neutrophils, epithelioid cells, and Langhan’s giant cells and
enclosed partially or completely by a fibrous capsule [53].
8. Clinical signs
The signs of tuberculosis in cattle usually vary depending on the organ systems
affected. In the early stages, clinical signs are not visible and many animals with
tuberculosis are clinically normal. The signs have a gradual onset characterized by
progressive weakness, debility, and mild fluctuating fever. Advanced lung involve-
ment is characterized by dyspnea, chronic moist cough, more marked in the morn-
ing and during cold weather, and reduced exercise tolerance [14]. Swollen lymph
nodes of the head may be observed and involvement of internal lymph nodes may
result in obstruction signs of the system or organ affected. There may be diarrhea or
constipation due gastrointestinal tract involvement. Mammary tuberculosis has
been found in varying proportions of animals, from 1 to 2%, up to 5.4% and is
characterized by persistent mastitis and hypertrophy [40]. Infertility or abortion
may result from tuberculous metritis, accompanied by chronic purulent vaginal
Figure 2.
Tuberculous lesions in the mediastinal lymph nodes of a goat meat carcass. ©2018. JKN Kuria.
71
Diseases Caused by Bacteria in Cattle: Tuberculosis
DOI: http://dx.doi.org/10.5772/intechopen.82051
discharge. Affected animals generally remain bright and alert and maintain a good
appetite despite weakness and sluggishness [57]. Acute or subacute death may result
from military tuberculosis, caused by rapid widespread dissemination, from pri-
mary or secondary lesions through the hematogenous route.
9. Public health importance
Zoonotic tuberculosis in cattle is a public health concern worldwide. The preva-
lence is estimated at 0.5–1% in developed countries and 10–15% in developing
countries [58]. In developing world, high levels of human immunodeficiency virus
(HIV) and poverty, especially in Sub-Saharan countries, are contributing factors.
Consumption of raw or undercooked products, and especially milk, from infected
cattle is the main cause of nonpulmonary tuberculosis [59]. M. bovis is excreted in
milk of about 1–2% of infected cattle in large numbers such that a single infected
cow can contaminate bulk milk by 100 cows to cause infection in susceptible
humans [60]. Social-cultural factors, for instance, the tradition by pastoral com-
munities to consume raw blood and milk and raw or undercooked meat and meat
products, are risk factors [1]. It is estimated that in Africa, 90% of milk is consumed
either raw or fermented, thus increasing the risk of transmission [61]. Cervical
lymphadenitis is the commonest manifestation of oral infection (Figure 3). Inhala-
tion of infected dust particles or aerosols shed by infected cattle is the second
important route especially in rural pastoralist communities. Abattoir workers,
farmers, milkers, veterinarians, and animal handlers are also exposed to this mode
of transmission [58, 62]. Infection in wildlife puts hunters, trappers, and zoo
workers at risk. Trans-cutaneous transmission may occur through handling of
infected carcasses [47].
10. Diagnosis
Tuberculosis in cattle can be diagnosed in live animals and also during postmor-
tem examination of dead or slaughtered carcasses. In live animals, clinical signs,
tuberculin skin test, and gamma interferon assay can be used. At postmortem,
pathological lesions and acid fast staining are preliminary tests while culture and
DNA analysis are confirmatory.
Figure 3.
Raptured lesion (arrowed) in the left retropharyngeal lymph node of a tuberculosis patient infected by M.
bovis. ©2018 JKN Kuria.
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10.1 Diagnosis by clinical signs
Clinical diagnosis may be difficult due to the chronic nature of the disease and
the wide variety of symptoms, resembling other chronic debilitating conditions.
The disease should be suspected on the basis of history coupled with signs of
progressive emaciation, in spite of good appetite, fluctuating temperature, chronic,
and moist cough dysphagia and noisy breathing. Enlargement of supramammary
lymph nodes may be observed. Differential diagnosis includes contagious bovine
pleuropneumonia, pasteurellosis Trueperella pyogenes pneumonia, bovine lympho-
sarcoma, traumatic pericarditis, and fascioliasis [63]. Animals suspected of tuber-
culosis infection should be thoroughly examined by palpation of all superficial
lymph nodes, the udder in females and percussion and auscultation of the pulmo-
nary area.
10.2 Tuberculin skin test
Tuberculin skin test is the standard procedure recommended by the World
Organization for Animal Health (OIE) for the diagnosis of bovine TB in live ani-
mals. This test measures the delayed type hypersensitivity response to tuberculin,
referred to as purified protein derivative (PPD), injected intradermally. There are
two variations of the test. The single intradermal test (SITT), which uses PPD from
M. bovis only (PPD-B), and the comparative intradermal test (CITT), which uses
PPD-B and PPD from Mycobacteria avium, (PPD-A). In the SITT, PPD-B is injected
intradermally in the neck region. A positive test is indicated by a delayed hyper-
sensitivity reaction (Figure 4). The skin thickness at injection site is measured with
a pair of calipers before and 72 hours after injection. A relative change greater than
4 mm in skin thickness at the site is considered positive for M. bovis infection [28].
The CITT is designed to address the cross-reaction between M. bovis and the M.
avium. PPD-B and PPD-A are injected side by side, around 12 cm apart, and skin
swelling is measured after 72 hours. The test result is considered positive, if the
relative difference in the increase of skin thickness at the site of PPD-B injection is
4 mm greater than that at the site of PPD-A injection [28]. The sensitivity and
specificity of the CITT has been estimated at 81–85 and 80.0, and 99.9%,
Figure 4.
A comparative intradermal tuberculin test in a cow showing a positive reaction. PPD-A was injected at site A
and PPD-B at site B. ©2018. JKN Kuria.
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respectively [58, 64]. The CTT has higher specificity than the SITT since it can
distinguish animals infected with nontuberculous mycobacteria, specifically the
MAC complex, which include M. avium subsp. paratuberculosis, the causative agent
of Johne’s disease. Other MOTTs species with ability to cross-react with M. bovis
have, however, been isolated from tuberculous lesion in cattle and related wild
species. The advantage of the CITT over the SITT is therefore limited [5–7].
10.3 Gamma interferon assays
The gamma interferon assay (IFNγ) is an in vitro form of the CITT. It is based on
detection of γ interferon produced by specific circulating lymphocytes upon stimu-
lation of heparinized whole blood in vitro with PPD-B and PPD-A. Detection of
IFNγ is carried by a sandwich ELISA, using two monoclonal antibodies to bovine
gamma-interferon, after incubation of the blood for about 16–24 hours with PPD-B
and PPD-A. The IFNγ test is reportedly more sensitive than the tuberculin test and
can detect infected animals that are negative to the later. The sensitivity and spec-
ificity are estimated at 81.8 and 99.1% [65]. It has been observed that more infected
cattle can be identified by using both the tuberculin and the IFNγ tests and it is
recommended that both tests be conducted in parallel [66]. The advantage of the
IFNγ is that infected animals are detected early and only one visit to the farm is
required. It is particularly convenient for animals that are difficult to capture or
handle, such as cattle reared in ranches or under nomadic pastoralism, or wildlife,
as they need only to be captured once rather than twice. It however requires more
technical expertise and facilities and is costly (approximately 10 USD, for consum-
able materials per test).
10.4 Postmortem diagnosis
Detection of tuberculosis using pathological examination involves visual obser-
vation, palpation, and incision of organs and tissue to detect lesions. A presumptive
diagnosis can be made on the basis of macroscopic granulomatous lesions
(Figures 1 and 2). Differential diagnosis includes parasitic and mycotic granulomas
and abscesses caused by other bacterial pathogens such as Actinomyces bovis,
Actinobacillosis, and Trueperella pyogenes, as well as bovine lymphosarcoma [67, 68].
Further, very small lesions may be missed and may only be detected microscopi-
cally. Routine postmortem meat inspection has been found to detect approximately
only 47% of presumptive lesions [69]. Direct smears of suspected lesions should be
stained by the acid fast method and examined for acid-fast bacilli (Figure 5).
10.5 Culture and isolation of mycobacteria
Culture is considered the “gold standard” for detection of Mycobacteria [69].
Samples for culture are first homogenized and decontaminated with sodium
hydroxide to inactivate any contaminant bacteria present in the sample, inoculated
into solid or liquid media and incubated at 37°C. Solid media include egg-based
Lowenstein-Jensen (L-J), Agar-based media such as Middlebrook 7H10, 7H11, and
Stonebrink Leslie solid culture media. Solid media is prepared as slants in screw-
capped bottles. In Lowenstein-Jensen media, malachite green dye (0.025 g/100 ml)
is used as a selective agent. Isolation should target MTBC and MOTTs and it is
recommended that each sample is inoculated into three tubes of LJ, one containing
glycerol, another pyruvate, and the other PNB. Most mycobacteria are obligatory
aerobic but M. bovis is microaerophilic. Screw caps should be loosened, to allow in
oxygen, and the tubes incubated in a slanting position, to allow bacteria to seed onto
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the media. Thereafter, the caps are tightened and the tubes incubated vertically for
six 12 weeks. Liquid media include BACTEC 460, Mycobacterial Growth Indicator
Tube (MGIT), which have enriched Middlebrook 7Ha with antibiotics and growth
promoters are added. BACTEC 460 MGIT media is fully automated and can moni-
tor the growth of mycobacteria by the use of oxygen quenching or fluorescent
sensor. Mycobacteria may not be recovered in the cultures for a number of reasons:
1. Extended period between sample collection and analysis, leading to death of
the organism.
2.Nonviability of the bacilli due to necrosis and calcification of granulomas.
3.Organisms may be inactivated by the decontamination process.
4.Samples may contain microorganisms other than mycobacteria.
Cultures suspected to be mycobacteria are then stained by acid fast method for
confirmation. All laboratory procedures must be conducted in a class II biosafety
cabinet in a laboratory environment that has been found safe and secure following
risk assessment.
10.6 Molecular diagnosis
Molecular tools for differentiating Mycobacterium species have been devel-
oped [70]. Polymerase chain reaction (PCR) technique involves detection of the
genetic material that is unique and specific to a species. Convenient commercial
kits are available. Genotype Mycobacterium (Hain, Nehren, and Germany) are
line probe assays available in three different formats: Genotype MTBC differ-
entiate species in MTBC; GenoType Mycobacterium common mycobacteria (CM)
detects most frequently encountered Mycobacteria species and Genotype Myco-
bacterium additional species (AS) detects less frequently encountered
Mycobacteria species. This kit uses reverse hybridization technology on a solid
membrane matrix consisting of nitrocellulose strips. The DNA probes are
immobilized on parallel lines on the strips. Biotinylated DNA apricon fragments
of the 16S-23SrRNA spacer region are incubated with the labeled strips and
hybridization detected colorimetrically by addition of an enzyme, Streptavidin-
alkaline phosphatase, and a chromogenic substrate. A precipitate is formed on
Figure 5.
Direct smear of a tuberculous lymph node lesion from a cow, showing presence of acid-fast bacilli (arrowed).
ZN  1000. ©2018. JKN Kuria.
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the membrane, where hybridization takes place. Another line probe assay is
INNOLiPa Mycobacteria (Innogenetics, Ghent, Belgium). Line probe assays are
convenient in that they can detect many species of mycobacteria simulta-
neously. The strips can also be conveniently dried and preserved.
AccuProbe (GEN-Probe, San Diego, California, USA), is an in-solution hybridi-
zation assay. DNA probes consisting of species-specific, single-stranded DNA oli-
gonucleotides are prepared complementary to ribosomal RNA released from
bacterial cultures and labeled with acridinum ester (chemiluminescent). Hybridi-
zation is measured by chemiluminescence using a luminometer and expressed as
relative light units (RLU). The test can be performed on culture growing from broth
or solid media and will detect all members of MTBC but without differentiating the
species. However, since no nucleic acid amplification occurs in the assay, identifi-
cation requires sufficient growth.
Real-time commercial PCR kits are also available for direct detection in
clinical specimens and pathological specimens but can also be used for identifi-
cation of cultures. The current available kits detect MTBC but not individual
species.
Restriction fragment length polymorphism (RFLP) or spoligotyping distin-
guishes between phenotypically different strains of M. bovis [71]. It is designed to
detect the unique spacers within the direct repeat (DR) locus of the M. bovis
genome [72] and is a useful epidemiological tool, in that it indicates strains circu-
lating in a population, and therefore the transmission patterns.
DNA tests are more rapid and reliable than the conventional identification
methods, but are still limited to the postmortem diagnosis of the infection, in that,
tissue samples or isolates are still required. Extraction and detection DNA in nasal
swab samples, milk, lymph node aspirates may however be achieved [73].
11. Economic impact
Economic losses due to tuberculosis in cattle worldwide are estimated at more
than US $3 billion annually [74]. This may be an underestimate since losses in many
developing countries have not been examined sufficiently or studied at all. Loss of
productivity of infected animals includes reduced milk yields, meat production, and
reduced fertility. Among dairy cattle, milk production may decrease between 4 and
18%. Other direct losses include mortalities, infertility, calf mortalities, additional
processing for infected animals, and condemnation of carcasses at slaughterhouses.
Export market restrictions constitute nontariff barriers to trade. The cost of control
involves meat inspection, test and slaughter of positive animals, pasteurization of
milk, and compensation schemes to farmers. The public health cost include cost of
treatment, mortality, loss of incomes and livelihoods, food insecurity, stigmatiza-
tion as well as extra working hours for those attending to sick humans [75, 76].
Globally, 147,000 new cases of zoonotic TB in humans were estimated in 2016,
resulting in 12,500 deaths. Most of the cases were in the African followed by the
South-East Asian region [43].
12. Control
Bovine tuberculosis is listed under the OIE Terrestrial Animal Health Code.
Control should be aimed at reducing prevalence in animals in order to prevent
transmission to humans. The recommended control method in livestock is continu-
ous detection and slaughter of infected animals [28]. Postmortem meat inspection
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and pasteurization of milk is an effective method of preventing infected animal
products from entering the food chain. Meat inspection can allow trace-back to the
herd of origin, which can then be tested and eliminated. Individual testing of cattle
and removal of infected and in-contact animals, coupled with animal movement
controls reduces prevalence [28]. Testing and slaughter may, however, not be
tenable in poor countries because of insufficient financial resources, pastoral pro-
duction method that is characterized by uncontrolled movement of animals, weak
veterinary institutions and political instability [28]. Further, in developing coun-
tries especially in Africa, cattle are raised together with sheep and goats, which act
as reservoirs and are not targets for test and slaughter.
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